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Abstract 
Three large Newfoundland families segregating with autosomal recessive hearing loss 
were studied in this thesis project: Family A, Family B and Family 41. Previous work on 
Family A identified a pathogenic mutation in the deafness gene PCDH 15 which 
explained deafness in five family members homozygous for the mutation but did not fully 
explain the deafness in five other fami ly members heterozygous for the mutation. A 
second deafness gene, CDH23 is located very close to the PCDH 15 on chromosome 10. 
Single mutations in these two genes are known to cause both Ushers syndrome and non-
syndromic deafness. All 69 exons and all intronlexons boundaries in CDH23 were 
sequenced in four Family A members which identified 45 S Ps. Only eight SNPs were 
potentially pathogenic because they were found in the coding region and they were 
polymorphic. However, no one variant of the eight SNPs segregated exclusively with 
deafness; in addition, all eight SNPs were previously reported as non-pathogenic. It was 
concluded that CDH23 does not contribute to the deafhess in Family A. Previous work on 
Family B determined the familial deafness was due to mutations in TMPRSS3: 
c. 782+ 3de1GAG, a novel mutation, and c.207de1C, a known mutation. Infonnative 
markers and intrageneic SNPs with the TMPRSS3 gene were used to con truct and 
characterize the two TMPRSS3 mutation haplotypes. A single copy of the novel 
TMPRSS3 mutation (c.782+3deiGAG) was found in a deafboy in Family 41 and his 
hearing mother and their TMPRSS3 haplotypes were constructed. It was found that 
carriers of the TMPRSS3 c.782+3delGAG mutation in Family Band Family 41 shared a 
haplotype spanning 1 O.lMb. Since the two fami lies are not known to be related, the 
TMPRSS3 c.782+3deiGAG was designated a founder mutation. 
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Chapter 1: Introduction 
Overview of Hearing Loss 
Hearing loss is a common sensory disorder and is prevalent in many populations. 
In the United States and the United Kingdom for example, l out of every I 000 live births 
is affected with hearing loss, and an equal frequency of children become deaf before the 
age ofmatmity (Bitner-Giindzicz 2002, Morton 2000). Furthetmore, the prevalence of 
hearing loss increases dramatically with age: I 0% of the population is affected by age 65 
and 50% by age 85 (Liu et al. 2007). 
The causes ofhearing loss are categorized as environmental (25%), genetic 
(50%) and unknown etiology (25%) (Willems 2000). However, the true percentage of 
hearing loss caused by genetic factors is greater than 50%, as the majority of hearing loss 
cases of unknown etiology are expected to be caused by genetic factors. As well, the 
environmental cases ofhearing loss are suspected to be influenced by genetic factors 
(Keats and Berlin 2002; Nance 2003). Of the deafness caused by genetic factors, 70% of 
the cases are non-syndromic, meaning the hearing loss occurs without any other 
symptoms, and 30% are syndromic cases, meaning the hearing loss is accompanied by 
maladies such as blindness (Ushers syndrome), progressive loss of kidney function 
(Alport syndrome) or branchial and renal anomalies (Branchio-oto-renal syndrome) 
(Keats and Berlin 2002). Among the explained cases ofnon-syndromic hearing loss, 88% 
of the identified genes are autosomal recessive, 11% are autosomal dominant, and 1% are 
either mitochondrial or X-linked genes. The most common genetic-type of deafness is 
autosomal recessive, non-syndromic deafness. Environmental cause of deafness include 
exposure to sustained high sound pressure levels ( >90decibels, dB, head trauma, 
ototoxic medication (ie. aminoglycoside antibiotics), prematurity, neonatal hypoxia, low 
bi1ih weight, evere neonatal jaundice, prenatal infection (eg. rubella, CMV) and 
postnatal infection (eg. cytomegalovirus, meningitis) (Willems 2000; Bitner-Glindzicz 
2002). Figure 1. 1 shows the relative percentages of each cause of hearing loss. 
Five factors are considered when describing the type of hearing loss. These are: 
age of onset, which frequencies are affected (ie. low, middle or high), the degree of 
hearing loss (measured in decibels), biological cause (ie. conductive, sensorineural or 
mixed) and configuration (ie. unilateral, one ear or bilateral). Table 1.1 outlines the sub-
classifications within these five factors. 
Figures 1.2 and 1.3 are examples of audio graphs taken from subjects u ed in this 
research study. An audiograph is a graph generated from a standard hearing test. The y-
axis scale measures sound intensity, in units of decibels (dB) which increases 
logarithmically. The normal threshold for hearing is OdB, which is a barely audible 
whi per. Persons with hearing loss have a higher than nonnal hearing threshold, meaning 
the sound intensity must be greater than OdB for them to hear. Persons with a mild degree 
of hearing loss can only hear at a sound intensity above 20dB, and persons with profound 
hearing loss cannot detect sound at all above > 1 OOdB (sound of a jet plane at ground 
level) (Table 1.2). The x-axis of the audio graph measures the frequency, or pitch, of a 
sound, in units of Hertz (Hz, number of cycles per second). Low pitch sounds have low 
frequencies (<500Hz), medium/middle pitch sounds have medium frequencies (500-
2000Hz), and high pitch sounds have high frequencies (>2000Hz). Heruing loss is 
characterized by intensity (mild, moderate, severe, etc.) and by which frequency is 
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affected (low, middle or high). The two lines on the audiographs represent either ear and 
are distinguished by colour or line hape. 
The individual who's audiogram is pictured in Figure 1.2 has been diagnosed with 
high frequency (>2000Hz), mild hearing loss (21-40dB) in both ears (bilateral). This type 
of hearing loss is common in older per ons who lose their hearing as a result of 
presbycusis. Age-related hearing loss, or presbycu i , i caused by a degeneration of the 
ear's sensory cells, and is characterized by a mild to moderate hearing loss at higher 
frequencies (Friedman 2003). 
The individual who's audiogram is pictured in Figure 1.3 has been diagnosed with 
profound hearing loss (> 1 OOdB), occmTing across all fTequencies and affecting both ears 
(bilateral). This type of hearing loss i a typical profile of hearing loss with a genetic 
cause because all frequencies are affected and the hearing loss occurs in both ears. 
Genetic Contribution to Hearing Loss 
Deafness is genetically heterogeneous, as most of the known genes cause the 
same type of deafness. As of May 2007, 12 1 non-syndromic deafness loci have been 
mapped and 47 genes have been identified (Hereditary Hearing Loss Homepage, 2006). 
Since the number of mapped deafness loci is more than twice the number of identified 
genes, there are at least another 50 non- yndromic deafness genes not yet described. 
Twenty-three of the identified non-syndromic genes cause autosomal dominant 
deafness and twenty-one cause autosomal recessive deafness. One gene has been 
identified as causing X-linked deafness, and two genes have found to cause 
mitochondrial inherited deafness. Interestingly, four genes (GJB2, GJB6, MY07A and 
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TMCJ) have been found to cause both autosomal dominant and autosomal rece sive 
deafness - the specific mutation detennines the resulting mode of inheritance. Table 1.2 
lists all the non-syndromic deafness genes identified to date (May 2007), as found on the 
Hereditary Hearing Loss Homepage. 
Most of the non-syndromic recessive deafness genes were mapped using large 
consanguineous families from geographically or ethnically isolated population uch as 
Tunisia, India and Lebanon (Bonne-Tamir et al. 1997). Since Newfoundland has a 
number of large consanguineous families which segregate with hearing loss, and the 
population is a genetically isolated population, Newfoundland has great potential for 
novel gene discovery in the field of heruing loss. 
As of May 2007, thirty syndromic genes for nine different syndromes have been 
identified to date (Hereditary Hearing Loss Homepage). A total of 13 loci and 9 genes 
have been mapped for Ushers syndrome - an autosomal recessive disorder characterized 
by hearing loss, visual loss and vestibular dysfunction (Ouyang et al. 2005). Ushers 
syndrome (or Ushers) is di vided into three subtypes, classified by severity: a person with 
Ushers Type [ (USHl), the most severe subtype, has congenital deafness, retinitis 
pigmentosa (RP) and early onset vestibular dysfunction; Ushers Type II (USH2) has 
moderate/severe hearing loss, no vestibular dysfunction, and early onset retinitis 
pigmentosa, and Ushers Type III (USH3), the least severe, has normal hearing and vision 
at birth, progressive development of both retinitis pigmentosa and hearing loss, and 
variable vestibular dysfunction (Online Mendelian lnheritance of Man, 2007). Ushers 
yndrome accounts for more than 50% of individuals who are both deaf and blind 
(Ouyang et al. 2005). 
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A number of deafnes genes cause both non-syndromic and syndromic hearing 
loss. Ushers syndrome Type I D (USH 1 D) is caused by a homozygous mutation in 
CDH23 and Ushers syndrome Type IF (USH 1 F) is caused by homozygous mutation in 
PCDH 15 (Online Mendelian Inheritance of Man, 2006). Allelic mutations in both 
PCDH/5 and CDH23 cause non-syndromic autosomal recessive hearing loss as well 
(DFNB 12 and DNFB23, respectively). It is predicted that missense mutations cause 
milder phenotypes (such as presbycusis and non-syndromic hearing loss) and null al leles 
cause more severe phenotypes (such as the Ushers syndromes) (McHugh et al. 2006). 
Evidence for this theory of genotype-phenotype con·elation has been reported for the 
Wolframin gene (WFSJ). Wolfram syndrome is a recessively inherited syndrome, 
characterized by deafness, diabetes-mellitus and optic atrophy. Interestingly, single 
mutations in WFSJ have been found which cause isolated autosomal dominant deafness. 
Mutations in WFSJ which are protein-inactivating cause Wolfram syndrome and 
mutations clustered in the C-tenninus of the protein and do not alter the protein function 
cause isolated deafness (McHugh et al. 2006). Evidence for this genotype-phenotype 
association has also been confirmed in CDH23 (Astuto et al. 2002). 
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Background on Newfoundland Population 
History of the Newfoundland Demographic 
The island ofNewfoundland, part of the Canadian province ewfoundland and 
Labrador, is the most easterly landmass in North America, and is separated fTom Europe 
only by the Atlantic Ocean. Historically, ewfoundland was discovered in 1497 by the 
European explorer Giovanni Gabotto (John Cabot) (although the Vikings from orway 
and Native Indians were Jiving here before this date). A report of Cabot's voyage to 
Newfoundland, written by Raimondo di Soncio of London to the Duke of Milan states: 
" ... The ea is full offish which a1·e taken not only with the net, but al o with a 
basket, in which a stone is put so that the basket may plunge into water. .. And the 
Englishmen, his [(Cabot' )] partners, say that they can bring so many fish that the 
kingdom will have no more business with lslanda [Iceland], and from thi s country there 
will be a very great trade in the fish they call stock fish ... " (Prow e, 2002, p.ll) 
Reports such a thi circulated throughout Europe during the 16th century, 
attracting many European to ewfoundland. Consequently, people from England, 
Scotland, Ireland, France and Portugal traveled to ewfoundland to harvest from the 
richest fishing ground in the world. However, when the fishing season was over, the 
Europeans returned back home since permanent re idency in Newfoundland was 
prohibited. And if this did not drive the fishermen away, the harsh Newfoundland winter 
and lack ofba ic supplies would have made a year-long stay a very unwelcoming option. 
Eventually however, the European fishermen adapted to ewfoundland ' climate, and 
they began to over-winter, remaining on the island for years at a time (Hancock 1989; 
Bennett 2002; Poole and Cuff 1994). 
By the early 1800 , the European fi he1men began to colonize Newfoundland 
b1inging their fami lies to the island, with no intension of returning to Europe. The 
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families of these European fishetmen are the founders ofthe Newfoundland population. 
The majority of these founders emigrated from either Southwest England or Southeast 
ireland. Once in Newfoundland, these people were brought to small, unpopulated inlets 
along Newfoundland's coast in groups of one or two families. The e settlements were 
very isolated because travel to other parts of the island was difficult and dangerous. This 
isolation led to intermatTiages (interbreeding) amongst the settler families, which carried 
on for many generations. Although these inlet communities are no longer geographically 
isolated, the years of inbreeding have left a significant impact on Newfoundland ' gene 
pool. This impact is reflected in the high rate of certain autosomal recessive diseases, 
which include hereditary deafness, Newfoundland rod-cone dystrophy, and Bardet Biedel 
Syndrome (Newhook eta!. 2004; Bennett 2002; Eicher eta!. 200 I; Ives eta!. 1991 ; Poole 
and Cuff 1994; Hancock 1989). 
High Occurrence of Consanguinity in the Population 
It is well documented that children of parents who are related have a higher 
percentage of homogenous alleles than children of umelated parents. Theoretical 
calculations predict a level of 6.25% homozygosity in the genome of children from first 
cousin maniages (Arab eta!. 2004), but empirical calculations suggest a higher level of 
homozygosity. For example, in a population with a long history of interbreeding, a level 
of 11 % homozygosity was found in the genomes of children whose parents are first 
cousins (Woods et al. 2006). 
Increasing the level of homogeneity increases the probability of inheriting two 
homozygous mutations resulting in a recessive disea e. The effect of inbreeding on 
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frequency of recessive diseases has been shown in diseases such as the 
hemoglobinopathie and in deafness (Arab et al. 2004). It is likely that inbreeding is al o 
responsible for the high incidence rate of certain recessive diseases in the Newfoundland 
population including Bardet-Biedl Syndrome, Type 1 diabetes mellitus and child-onset 
severe deafness (Moore et al. 2005; Newhook et al. 2004; Ives et al. 1991 ). The table 
below compares the frequencies of these recessive diseases found in Newfoundland 
compared with reference populations. Although it is saddening that the numerou 
generations of inbreeding in the Newfoundland population has led to high incidence rates 
of particular recessive diseases, these large, consanguineous families hold great potential 
for novel gene discovery. 
Prevalence of Three R ecessive Diseases in Newfoundland Compared with Prevalence 
in Other Populations 
Disease Frequency in Reference Comparable Reference 
Newfoundland Population 
Population 
Bardet-Biedl 5.6/l 00,000 Moore et al. 0.63-0.81100,000 Moore et al. 
Syndrome 2005 (European) 2005 
Type I 35.93/100,000 Newhook et 24.5/100,000 Newhook et al. 
Diabetes (A val on Peninsula) al. 2004 (PEl) 2004 
10.1/ 100,000 
(Montreal) 
Child-onset 1.2-9.5/1000 lves et al. 1/1000 Morton, 
Severe (Southwest coast) 1991 (US population) Annal New 
Deafness York 
Academy of 
Sciences 
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Newfoundland is a Founder Population 
A founder population is a subpopulation originating from a larger group, which 
has been isolated due to factors such as geography, culture or religion. Founder 
populations are subject to the "founder effect", whereby alleles from the original 
population are subject to random genetic drift and are either overrepresented, 
underrepresented or absent in the founder population. As a result of this random genetic 
drift, founder populations may have an elevated incidence of particular genetic disorders 
yet rare cases of other genetic disorders. A high prevalence of a di ease-cau ing mutation 
provides evidence that a population has experienced the predicted outcome of the founder 
effect. Since Newfoundland is a subpopulation of the larger European population, 
isolated from Europe by geography and has undergone expansion in relative isolation, it 
is considered a founder population. 
A founder mutation is a pathogenic mutation in a founder population that is found 
in two or more unrelated families that originates from the same ancestor. A number of 
founder mutations have been identified in the Newfoundland population. These include 
mutations in MSH2, a gene causing hereditary non-polyposis colorectal cancer; an exon 8 
deletion has been found in 5 different families (N=74 carriers) and an intron 5 splice site 
mutation (c.942+3A>T) has been found in 12 different families (N= 151 caniers) 
(Stuckless eta!. 2007). As well, M390R, a mutation in BBSJ causing Bardet Bieda! 
Syndrome, has been identified in 6 different families (Moore eta!. 2005). This thesis also 
reports a founder mutation in the deafuess gene TMPRSS3 c.782+3de!GAG, which was 
identified in two Newfoundland families. These are only a few of the many examples of 
founder mutations which have been identified in the Newfoundland population, providing 
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evidence that Newfoundland is a founder population which has been subject to the 
founder effect. 
Identifying Founder Haplotypes 
A founder mutation is confinned by building a haplotype flanking the 
clu·omosomal area around the mutation. Haplotypes which include a founder mutation are 
called founder haplotypes. Founder, or ancestral, haplotypes are expected to be common 
in founder populations. Many founder haplotypes, segregating with founder mutations, 
have been identified in the Newfoundland population, including a TMPRSS3 haplotype 
(deafness), an MSH2 haplotype (hereditary non-polyposis colorectal cancer) and a BBSJ 
haplotype (Bardet-Biedel Syndrome) (Stuckless et al. 2007; Moore et al. 2005). 
Identifying Disease Genes 
Determining Pattern of Inheritance in a Family 
The first step of identifying a genetic cause for a disease is determining the 
disease pattern of inheritance. This is done by examining the affection (disease) status 
from as many fami ly members as possible to identify a recognizable pattern of 
inheritance. In autosomal dominant diseases, affected children have affected parents, and 
all generations in the pedigree are affected. In autosomal recessive diseases unaffected 
parents have affected children and the disease may skip generations. Both sexes inherit 
the mutation equally. In the remaining modes of inheritance, the sexes are affected 
differently. In X-linked recessive inheritance, the majority of affected are males whi le in 
X-linked dominant inheritance, affected fathers will have affected daughters but 
unaffected sons. An affected mother with an X-linked dominant mutation will have one-
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half sons affected and one-half of daughters affected. Y -linked is only male to male 
transmission, and mitochondrial inheritance passed on only through the maternal line 
(Griffiths et al. 2002). 
In order to accurately identify the disease pattern of inheritance in a family, the 
cause of the disease for each affected individual must be carefully described. Although a 
number of affecteds in the same family does indicate a genetic disease, it is possible that 
some fami ly members may have the disease due to a non-genetic cause. An affected 
fami ly member who ha a non-genetic phenotype is called a phenocopy. It is important to 
use affected family members with a suspected genetic cause for a genome wide scan 
(technique used to identify disease gene), as a single phenocopy may render the entire 
results erroneous. 
Identifying Candidate Disease Genes 
Once the disease pattern of inheritance has been confidently identified, the next 
step is to compi le a list of possible candidate genes - genes with disease-causing 
potential. These include any known disease genes, especially any which had been 
previously identified in the studied population, and any genes which are known to play a 
role in the pathology of the disease. Selected candidate genes are sequenced in affected 
individuals to search for a disease-causing mutation. 
However, if a candidate gene cannot be identified -meaning that all the identified 
candidate genes have been sequenced and no mutation was identified, or the list of 
possible candidate genes is too extensive- the next step in disease gene identification is a 
genome wide scan (GWS). 
II 
--------------------------------
Explanation of Genetic Tools and Techniques 
Genome Wide Scan and LOD Score 
The goal of a genome wide scan is to detennine if a disease locus is common 
amongst affected family members. The GWS is perfonned using a few hundred evenly 
spaced microsatellite markers and requires DNA of family members from every affected 
sibship, every generation (both affected and not) and from both affected and unaffected 
family members. A LOD score (Logarithm of the ODds) is generated for each 
microsatellite marker. The LOD score is the logarithm of the ratio of two probabilities: 
probability l - the marker and disease gene are linked (9=0), and probability 2 - the 
marker and disease gene are not linked (9=0.5). The LOD score is generated for various 
linkage distances, and the distance with the highest LOD score is taken as the most 
probable. A LOD score of 3 is generally considered to be significant; a LOD score of2:3 
means there is a high probability (1 000:1) that the marker is linked to a disease gene 
(Twilliger and Ott 1999). 
Use of MicrosatelJite Markers to Construct Haplotypes 
Common throughout the genome are areas of tandem DNA repeat , called 
microsatellite sequences. These microsatellites range from dinucleotide repeats (eg. TA) 
to a six-base repeats (GAAGTC). If the repeat number of the micro atellite is 
polymorphic, meaning the tandem D A repeat number is variable in the population, it 
can be used as a genetic marker. For example, the dinucleotide microsatellite TA is 
polymorphic if it is repeated twice in one person (TAT A) and three times in someone else 
(TAT AT A). These microsatellite markers are useful for comparing DNA from two or 
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more individuals. Genotypes from these markers are used to construct haplotypes. 
Depending on the subjects that are selected for genotyping, the variant may or may not be 
polymorphic. If all genotyped subjects have the same variant, the marker is "non-
infonnative" since it provides no differentiating information between the subjects. 
Conversely, if subjects have variants of a genotype, the marker is "informative". 
If a significant LOD score is generated for one of the microsatellite markers, the 
chromosomal locus surrounding the marker with the high LOD score is mapped using 
additional markers. These markers are used to create a short, well-defined map in the area 
with the high LOD score. The genotypes fi·om these markers are used to build haplotypes 
- blocks of linked alleles which are passed on intact fi·om parents to offspring. If all 
affected family members share a haplotype (two haplotypes for autosomal recessive 
diseases) there is a good chance the disease gene resides within the boundaries of the 
haplotype. 
To determine which gene within the haplotype is the disease-causing gene the 
process for identifyi ng candidate disease gene is repeated (ie. identifying candidate genes 
and sequencing). If sequencing candidate genes does not identify a disease mutation, all 
genes in the identified haplotype region may need to be sequenced in order to identify a 
disease-causing mutation. 
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Figure 1.1 - Causes of hearing loss by percentage. Graph A shows the percentage contribution from each of the three major causes 
of hearing loss. Graph B is a sub-graph of Graph A; Of Genetic Hearing Loss, 30% is Syndromic and 70% is Non-syndromic. Graph 
Cis a sub-graph of Graph B; OfNon-syndromic Hearing Loss, 1% is Mitochondrial or X-linked, 22% is Autosomal Dominant and 
77% is Autosomal Recessive. 
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Figure 1.2- Audiology chart of a hearing individual with mild hearing loss at the high 
frequencies. The different colours differentiate the two ears. 
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Figure 1.3- Audiogram of an individual with profound, bilateral, sensorineural hearing 
loss. The hearing loss is across all frequencie , occurs in both ears, and the individual 
cannot detect sound of < 1 OOdB. This type of hearing loss is the mo t evere, and is 
characteristic of hereditary hearing loss. 
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Table 1.1: Classification of Hearing Loss 
Onset 
Birth Congenital 
Pre-lingual Before Speech 
Post-lingual After Speech 
Degree 
Normal hearing Between 0-90dB 
Mild hearing loss Cannot detect sound below 21 -40dB 
Moderate Cannot detect sound below 41 -60dB 
Mod Severe Cannot detect sound below 61 -BOdB 
Severe Cannot detect sound below 81-1 OOdB 
Profound Cannot detect sound <1 OOdB 
Configuration 
One ear Unilateral 
Two ears Bilateral 
Frequency 
Normal 20-20 000 Hz 
Low Frequency <500Hz 
Middle Frequency 501-2000 Hz 
High Frequency >2000Hz 
Biological Cause 
Sensorineural 
Conductive 
Mixed Both sensorineural and conductive 
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Table 1.2: Non-Syndromic Deafness Genes Identified to Date 
(Hereditary Hearing Loss Homepage, April 2007) 
Autosomal Dominant (AD) 
Autosomal Recessive (AR) Gene Name 
X-linked (X) 
AD CRYM 
AD DIAPHJ 
AD GJB3 
AD KCNQ4 
AD MYH/4 
AD DFNA5 
AD w~ 1 
AD TECTA 
AD COCH 
AD EYA4 
AD COLL/IA2 
AD POU4F3 
AD MY/-19 
AD ACTGI 
AD MY06 
AD TFCP2L3 
AD MYOIA 
AR MY0/5 
AR SLC26A4 
AR TMIE 
AR TMPRSS3 
AR OTOF 
AR CDH23 
AR STRC 
AR USH! C 
AR TECTA 
AR OTOA 
AR PCDH/5 
AR TRJOBP 
AR CLDN/4 
AR MY03A 
AR WHRN 
AR ESPN 
AR MY06 
AR TM/-IS 
X POU3F4 
AR!AD GJB2 
AR!AD GJB6 
AR!AD MY07A 
ARJAD TMCI 
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Introduction 
Family History 
Chapter 2: Family A 
Family A is a large Newfoundland family from a small isolated community on the 
Southwest coast ofNewfoundland. The complete pedigree documents 150 people, 
extends back six generations and reports four cases of consanguinity. The names and 
dates in the pedigree suggest the founders of this fami ly may have also been the founder 
of the community. Twelve Family A members have been diagnosed with autosomal 
recessive, non-syndromic hearing loss which ranges in degree from mild to severe-
profound. A summary of the audiology reports for twenty family member can be found 
in Table 2. 1. A partial pedigree of Family A is shown in Figure 2.1. 
Previous Research on Family A 
Identification of a Deafness-Associated Haplotype 
Previous work on Family A was conducted to determine which gene(s) was re ponsible 
for the family's deafness. A genome-wide scan (GWS) was perfonned on 32 Family A 
members. A marker which has a LOD core 3.0 or greater indicates a high probability the 
disease of interest segregates with the marker. A significant LOD score (1ogarithm of the 
ODds) of3.96 was generated for marker DJOSJ96, located on chromosome 1 Oq22 
(Figure 2.2) (Young, personal communication). In order to narrow the critical region, two 
markers flanking either side of DJOSJ96 were typed in 16 Family A members (Figure 
2.3). The alleles at the proximal marker DJOS208 did not segregate with either allele at 
DJOSJ96, but an allele at the distal marker DJOS1652 did segregate with an allele at 
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D10S196 in 13 of the typed family members. It was determined that a disease haplotype 
must be distal to D10S196. The chromosomal area in this identified region was fine-
mapped with additional markers and a common haplotype of 16.5 Mb was identified in 
22 family members. A list of markers used for fine-mapping is found on Table 2.2. 
Figure 2.4 is a partial pedigree of Family A and displays the haplotypes which resulted 
from fine-mapping the area of intere t on chromosome 10. All persons who carried two 
copies of the (yellow) haplotype were deaf, including T-1 0 and T-14 in sib-ship 3, T -16 
in sib-ship 4, and T-7 and T-9 in sib-ship 5. Since this haplotype egregated with 
deafness, it was classified as a deafness-associated haplotype. The upper boundary of thi 
haplotype can be clearly defined because the marker D10S196 is informative. However, 
the marker at the lower boundary D 1 OS1646 is not a informative, and it is not clear 
whether or not the haplotype ends at this marker. 
Identification of the Deafness-Causing Gene, PCDH15 
Two deafness genes are located on chromosome 10, in the same region as the 
defined deafness-associated haplotype - PCDH 15 (protocadherin 15) and CDH2 3 
( cadherin23). The PCDH 15 is located in the middle of the deafne s-associated haplotype 
(55.3Mb on chromosome 10). Consequently, this gene, located in the area with the 
significant LOD score, segregates with the deafness-associated haplotype. The CDH23 
gene is located just outside the deafness-associated haplotype (72.9 Mb on chromosome 
10). Although the CDH23 gene is adjacent to the deafness-associated haplotype, it does 
not always egregate with deafness. Since the PCDH15 gene segregated with the 
deafness-associated haplotype consistently, it was selected for full sequencing. 
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The Protocadherin 15 gene is composed of 33 exons, spans 1.6 Mb on 
chromosome 1 Oq21.1 and codes for 1955 amino acids. The start codon is in the middle of 
the second exon at 396bp and the stop codon is in exon 33 at 6,263bp. Two deaf 
members in Family A (T-16, T-17) and two individuals with n01mal hearing (unaffected 
Family A member (T-23) and non-Family A member with Newfoundland ancestry) were 
sequenced all PCDH I 5 exons and intron/exon boundaries. A SNP found in PCDH I 5 
exon 13, designated c.l583T>A, was suspected to be pathogenic because it was 
homozygous in the two deaf individuals and heterozygous or wild-type in the two hearing 
individuals. To detennine whether the mutation segregated with deafness consistently, a 
number of additional Family A members were sequenced for the c.1583T>A variant, 
which determined that all family members homozygous for the S P were deaf and those 
heterozygous were both deaf and hearing. The genotypes for each individual sequenced 
for the PCDHI 5 mutation are given in Table 2.1 and are marked on the pedigree in 
Figure 2.4. 
All cadhetin proteins, including protocadherin 15 (PCDH 15) have a conserved 5-
repeat calcium-dependant binding motif. The function of these binding motives is to 
allow PCDH 15 to interact with other proteins; a mutation in one of these con erved 
domains could disrupt the entire function of PCDH 15. The PCDHI 5 c.1583T>A SNP 
causes a missense substitution (Val528Ala) in one of these conserved binding motif and 
consequently was suspected to be a potentially pathogenic mutation. 
The PCDHI 5 c.l583T>A SNP explained the cause of deafness in five deaf 
Family A members homozygous for the mutation. Individuals T- 1 0 and T-14 in ib-ship 
3, T-16 in sib-ship 4, and T-7 and T-9 in sib-ship 5 are all homozygous for the PCDHI5 
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mutation and have two copies of the deafi1ess-associated haplotype. The deafness in these 
individuals is considered "solved". Deaf individuals T-19, T-20, T-1 and T-3 in sib-ship 2 
and T -30 in sib-ship 1 are all heterozygous for the PCDH I 5 mutation and cany a single 
copy of the deafuess-associated haplotype; sequencing the full length PCDHJ 5 gene in 
selected family members did not identify any other potentially pathogenic SNPs. 
Individuals T-1 and T-3 were screened for mutations in connexin 26 (Cx26) and connexin 
(Cx30), the two most common deafness genes and for the three known Newfoundland 
deafi1ess mutations (c.2146G>A in WFSJ and c.207delC and c.782+3delGAG in 
TMRPSS3). These individuals did not carry any of the named mutations (Young, 
personal communication). 
The previous research on Family A concluded that the PCDH15 c.l583T>A 
mutation could explain the deafness in sib-ships 3, 4 and 5 but could not fully explain the 
deafuess in sib-ships 1 and 2. It is of interest to note that the phenotype of the deaf 
individuals in sib-ship 2 differs from the other affected family members. It has been 
reported by researchers who have visited this family that the deaf siblings in sib-ship 2 
can speak, which is indicative of a post-lingual hearing loss. By contrast, the audiology 
chart fi·om T-16 in sib-ship 4 reports he has no speaking ability; the chart from T-9 in sib-
ship 5 reports her onset of deafi1ess was at 18 months (pre-lingual). Since the deafuess 
phenotype in sib-ship 2 differs in its onset, the affecteds in this sib- hip may have a 
different type of deafuess and a different genetic cause. It is also possible that the 
deafness in this sib-ship may not have a genetic cause and these siblings may be 
phenocopies. Environmental causes include severe neonatal jaundice, rubella, 
cytomegalovirus (CMV) and meningitis (Willems 2000, Bitner- Glindzicz 2002). 
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Digeneic Inheritance Between PCDH15 and a Second Deafness Gene, CDH23 
Zheng et al. (2005) reported a human case ofU hers syndrome (deafness, 
blindness) which was caused by the interaction of single mutations in PCDH 15 and 
CDH23 (c.5601 delACC/+ in PCDH15 and c.l93de1C/+ in CDH23). Additionally, the 
same study reported double heterozygous mice presented with non-syndromic deafness. 
Two single mutations in two different genes which interact to produce a disease 
phenotype and segregate in an autosomal pattern of inheritance i called digeneic 
inheritance (Reiners et al. 2006). 
The PCDH 15 c.1583T>A mutation segregated with the deafness-associated 
haplotype carriers in Family A which could explain deafness for five family members 
from sib-ships 3, 4 and 5. Five affected fam ily members from sib-ship I and 2 were 
heterozygou for the PCDH 15 mutation and their deafness could not be explained by 
PCDH 15 alone. 
The deafnes gene CDH23 resides at 4.7 Mb outside the deafness-associated 
haplotype and does not segregate with the chromosomal area with the significant LOD 
score (identified by the genome-wide scan). However, in light of findings by Zheng et al. 
(2005) on the digeneic interaction between mutations in PCDH 15 and CDH23, and since 
a single mutation was previously identified in PCDH 15 in deaf Family A members, it 
was hypothesized that a single mutation in CDH23 could interact with the PCDH1 5 
mutation which might explain the deafness in the unexplained sib-ships. 
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Goals for Family A Research 
The goal ofthis research is to determine ifCDH23 (a known deafness/Ushers syndrome 
gene) contributes to the genetic etiology of the hearing loss in a large inbred 
Newfoundland family, Family A. 
Objectives 
1. Sequence CDH23 in three deaf siblings (T-20, T-1 , T-3) from sib-ship 2 and one 
hearing relative (T-5), all heterozygous for the PCDH 15 c. l 583T>A mutation. 
Determine whether if any of the CDH23 SNPs are pathogenic. 
2. Use the infonnative CDH23 SNPs to construct CHD23 intrageneic haplotypes -
(haplotypes composed of variants from the one gene). Determine whether the deaf 
siblings in sib-ship 2 share a common CDH23 intrageneic haplotype. 
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T3B T32 T2B 
T33 T29 T.D T31 T19 r.D T1 T2 T3 T4 T5 T10 T11 T12 T13 T14 T22 TZ3 T16 T15 1'2412> T27 1m 
T6 17 T8 19 T21 
Figure 2.1 - Partial pedigree of Family A showing family members affected with bilateral, non-syndromic, sensorineural hearing loss (black 
symbol). Family members with unknown or non-genetic types of hearing loss are not identified in this pedigree. The horizontal line across the top of 
the symbol means an audiology report is available for the individual. 
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D105196 
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2.000 
-2.000 
·4.000 
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-8.000 
Figure 2.2: Plot of all LOD scores across the genome for Family A (Young, personal 
communication). The numbers on the x-axis represent the autosomal chromosomes (ie. 
I= chromosome 1). They-axis gives the LOD scores (axis on a logarithmic scale). The 
points represent the maximum LOD score for each marker. A LOD score >3.0 is 
significant, meaning there is a high probability (1: 1000) that the disease trait is linked to 
the marker. In this case, the disease trait is deafness. The maximum LOD score on this 
chart is from marker DJOSJ96 on chromosome 10, with a LOD score of - 4.0, meaning 
there is a high probability (1: 10,000) that dearness segregates with marker DIOSJ96. 
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Figure 2.3: Markers used to narrow the critical region around marker DJOS196 
(Young, personal communication) Marker fl anking either side of DIOS1 96 were used 
to determine if the haplotype was proximal or distal to this marker. 
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Figure 2.4: Carriers of the PCDHJS deafness-associated haplotype (Young, personal communication). The PCDH 15 deafness-
associated haplotype is highlighted by the yellow bar. Red numbers represent sib-ships. The legend is list of microsatellite markers 
used to map the haplotypes (University of California Santa Cruz, 2006). Some haplotypes have been inferred (brackets) . 
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Identification of the PCDH15 Deafness-Associated Haplotype 
To accompany Figure 2.4 
I. The yellow haplotype represents the PCDH15 deafness-associated haplotype, 
defined between markers DJOS196 and DJOS1646 and includes the PCDH15 
mutation c.1583T>A. This PCDH 15 c.l583T>A mutation is potentially pathogenic. 
II. The PCDH15 c.1583T>A mutation can explain the deafness in sib-ships 3, 4 and 
5. All deafindividuals in sib-ship 3 (T-10, T- 14), sib-ship 4 (T-16) and sib-ship 5 (T-7 
and T-9) are homozygous for the PCDH/5 c.l583T>A mutation. The deafness in 
these ib-ships is considered solved 
III. The PCDH15 mutation by itself cannot explain the deafness in sib-ships 1 and 2. 
The affecteds in sib-ship 1 (T-30) and in sib-ship 2 (T-19, T-20, T- 1 and T-3) are 
heterozygous for the PCDH 15 mutation and carry a single copy of the PCDH 15 
haplotype. 
IV. The PCDH15 deafness-associated haplotype for T-20 has a suspected cross-over 
at DJOS524 or at DJOSJ652. Since the allele at DJOS1652 i non-info1mative, the 
cross-over may have occurred at either of these markers. The full length deafness-
associated haplotype has been defined in sib-ships 3, 4 and 5, providing evidence that 
T -20 has a recombinant PCDH 15 haplotype. 
V. The PCDH15 deafness-associated haplotype for T -1 has a suspected cross-over at 
DJOS546. Similar for T-20, the PCDH15 haplotypes defined in sib-ships 3, 4 and 5 
provide evidence that T-20 has a recombinant PCDH15 haplotype. 
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Figure 2.5- Genetic Map of Markers used to Construct the Deafness-Associated 
Haplotype on chromosome 10. Markers start from centromere. Markers selected from 
Genome Browser (University California Santa Cruz, 2006). Map also shows loci of 
PCDHI5 and CDH23. 
51.8Mb~I--_.:D 1 OS 196 
52.3Mb DIOSI220 
54.8Mb~I---.DIOSII22 
55.3Mb PCDHI5 
55.8Mb DIOS546 
64.1 Mb~I---D 1 OS1652 
72.9Mb~i---CDH23 
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Table 2.1: Summary of Latest Audilogy Reports and PCDH15 Mutation Status on Family A members 
Pedigree# Age Gender Type of Hearing Loss PCHD15 Age of Last Available Other Information ascertained from 
{years) F=female c. 1583 T>A Onset Audiology pedigrees and audiology reports 
M=male {year) 
T1 65 F Profound NSHL Aff n/avail n/avail Speaks a few words 
T2 60 F none Tff n/applic 1997 none 
T3 56 F NSHL Aff n/avail n/avail Not born deaf. Can hear loud noises 
T4 77 M none Aff n/applic 1997 none 
TS 80 F none Aff n/applic 1997 none 
T7 39 M Profound NSHL n/a n/avail n/avai l none 
T9 37 F Moderate-Severe NSHL A/A 18 months 1994 none 
T IO 59 F NSHL NA n/avai l n/avail none 
Til 80 M none Tff n/applic n/applic none 
Tl2 77 F none Aff n/applic 1997 none 
Tl3 43 M none Tff n/applic 1997 none 
Tl4 54 F NSHL n/avai l n/avail n/avai l none 
TIS 63 M none Aff n/applic 1997 none 
Tl6 56 M Profound NSHL A/A n/avail 1997 Surgery fo r growth in RE tunnel (ciJ 22 years 
Tl9 69 F NSHL Aff n/avail n/avail Sick when young. HL may not be genetic 
T20 - M NSHL Aff n/avail n/avail none 
T22 57 M none Aff n/applic n/applic none 
T25 69 F Mild-Moderate Right Ear only Aff n/avail 1997 none 
T29 66 M none Tff n/avail n/avai l none 
T30 58 M NSHL Aff n/avail n/avail none 
Note: n/avail = not available n/applic = not applicable NSHL= non-syndromic hearing loss 
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Table 2.2: Physical Location of Markers used to Create the PCDH15 Deafness-
Associated Haplotype and Locus of PCDH15 and CDH23. The markers were taken 
from Genome Browser (University California Santa Cruz, 2006) 
Marker/Gene Location on 10q21-22 Type of Nucleotide Heterogeneity 
Dist from centromere (bp) Repeat 
DJOS196 51,812,274 Dinucleotide 0.79 
DJOS1220 52,348,388 Trinucleotide n/a 
DIOSJJ22 54,839,814 Dinucleotide 0.78 
PCDH/5 55,251,058 n/a -
DJOS546 55,764,404 Dinucleotide 0.68 
DIOS1652 64,077,501 Dinucleotide 0.78 
CDH23 72,869,595 n/a -
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Methods 
Subject Recruitment 
Family A members were recruited through the Newfoundland Provincial Genetics 
Program, initiated in 1988 by Dr. E Ives. Research participants were required to give 
informed consent, which granted researcher permission to access medical records and 
family history. A blood sample (for DNA) was taken from all participants who were able. 
This project was approved by the Human Investigations Committee (HIC), Research 
Ethics Board ofMemorial University, Newfoundland and Labrador(# 01. 186). 
Audiological tests were performed by a local physician to detennine the type of hearing 
loss of affected individuals and to confirm notmal hearing in non-affected per on . 
Physical exams (also perfonned by a local physician) were performed to determine 
whether affected persons were affected with other conditions (ie. syndromic hearing 
loss). Vision and ve tibular functions were perfonned to test for Ushers yndrome. 
CDH23 Sequencing Primers and Conditions 
Both the forward and reverse strand of each CDH23 exon (69) was sequenced to ensure 
the entire coding region was covered. The intron!exon boundaries were also sequenced as 
the primer are intronic. Primer sequences and specific PCR requirements for each exon 
can be found in Boltz et al. 2001 and in Appendix C. 
DNA Preparation, PCR Thermo-cycling, and Electrophoresis 
DNA was extracted from whole blood and diluted to I OOng/J..tl and was stored at 4°C 
(performed by lab staff). Then I f.lL of diluted (stock) DNA was added to 2.5J.!L I OX 
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PCR Buffer, 2 . 5~-tL dNTPs (2mM), 0.75~LL MgCh (50mM), 0.2 L Taq polymerase (5 
U/~-tL) , 16.05~-tL of distilled dH20, 1.0~-tL of forward primer ( l 0~-tM) and 1 .0~-tL of reverse 
primer ( 10~-tM). 5.0~-tL of dH20 was replaced with betaine to enhance PCR product yield 
when needed. The mix was then centrifuged briefly of which 25~-tL added to each well on 
the PCR plate, sealed and centrifuged briefly and was placed in the AB I thermo-cycler. 
Each primer pair had specific thenno-cycler conditions (Boltz et al. 200 I or Appendix 
C). The post-PCR products were run on a I% agarose gel (1 g agarose/ 1 L TBE), stained 
with ethidium bromide, and viewed under UV light on the Kodiak Molecular Imaging 
sy tern (Carestream Health, lnc. Rochester, NY, Version 4.01, 2005). 
Preparation for ABI Cycle Sequencing 
After re-suspending the Sephacryl 300, 300~-tL of the solution was added to each 
well on a silent screen plate. A plastic waste plate was placed undemeath the si lent screen 
plate to catch the flow through. The two adjacent plates were balanced and centrifuged at 
3000rpm for 5 minutes and any flow-through in the plastic waste plate was discarded. 
The PCR products were then added to the wells on the silent screen plate and a clean 
PCR plate was added beneath the silent screen plate. The two adjacent plates were 
balanced and centrifuged 3000rpm for 5 minutes. The flow-through product collected in 
the PCR plate contained the Purified PCR products. 
Succes ful amplified PCR products, visualized as band of the appropriate size on 
an agarose gel, were prepared for sequencing using the following cocktai l: 1~-tL of 
sequencing mix, 2~-tL 5X sequencing buffer, 2~-tL of either forward or reverse p1imer 
(1 .6~-tM) , 1~-tL of DNA template (Purified PCR product) and 14~-tL of dH20 (total volume 
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of20J..LL). The mixture was then centrifuged briefly and the samples were denatured on 
the thermo-cycler (25 cycles of 96°C at I minute, 96°C for 10 seconds, 50°C for 5 
seconds, 60°C for 4 minutes and held at 4°C when completed). After denaturing, the 
samples could either be stored or continued to be prepared for sequencing. Stored 
amples were held at -4°C for a maximum of 3-6 months. 
lJ.!L of purified PCR product, 5J.!L of 125mM EDTA and 65J.!L of95% ethanol 
(EtOH) was added to each reaction well in a sequencing plate, and was vortexed and 
centrifuged. The mixture was precipitated for 1 hour to overnight, in a dark space at room 
temperature. After precipitation had occurred, the plate was centrifuged for 30 minutes at 
3000g and ubsequently was gently inverted to decant the ethanol. A folded paper towel 
and a plate carrier (used as a weight) were placed underneath the inverted plate and were 
collectively centrifuged very quickly to 200rpm. A volume of 150J.!L of70% EtOH was 
added to each well and the plate was centrifuged again for 15 minutes at 3000g. 
Subsequently, the plate gently inverted to decant the ethanol. A paper towel and a plate 
carrier were placed underneath the inverted plate, which was then centrifuged until a 
speed of200rpm was reached. The plate with the samples was left to dry in the dark for 
15 minutes. 30J.!L ofDMF (dimethylformaamide) was added to each well. The plate was 
then votexed and centrifuged briefly. The final mix was denatured at 95°C for 2 minutes 
on a thermo-cycler (30J..LL of dH20 was added to any empty wells in rows that had 
samples). Once denatured, samples were kept on ice until they were place in the ABI 
3130 Automated Sequencer. 
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Automated Sequencing Using the ABI 3130 
Automated sequencing was perfonned using the ABI Prism 3130 Genetic 
Analyzer (Applied Biosystems, Foster City, CA). The raw sequence data were inspected 
manually (for quality) using Sequencing Analysis software. Good (clean) equences were 
loaded into a program called Mutation Surveyor (Version 3.0, Softgenetics, State 
College, PA). Mutation Surveyor automatically detects D A sequence variant in the 
sample DNA by comparing it to a reference gene sequence; the CDH23 reference 
sequence was obtained from University California Santa Cruz genomic databank 
(University California Santa Cruz, 2006, Accession # AF312023). The informative SNPs 
were used to construct CDH23 intrageneic haplotypes. The haplotypes were constructed 
manually and were not computer generated. Mutation and protein naming of identified 
CDH23 SNP are taken from Human Genome Variation Society Homepage, 2007. 
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Results 
The purpose of this study was to sequence CDH23 in selected Family A members 
to determine if a mutation in this gene can explain deafness in sib-ships 2. Four family 
members were selected for sequencing, three of whom are deaf and one who has nonnal 
hearing (Figure 2.4, Persons T-20, T-3, T-1 and T-5, respectively). The three deaf 
individuals are from sib- hip 2 and the hearing individual is a first cousin to these 
siblings. All four sequenced individuals are heterozygous for the PCDH15 c.1583T>A 
mutation. It was hypothesized that a single mutation in CDH23 might explain the 
deafness in these PCDH 15 heterozygotes since the interactions between two single 
mutations in both PCDH15 and CDH23 has been demonstrated to cause both Ushers 
syndrome and non-syndromic deafness (Zheng et al. 2005). 
The sequencing of CDH23 in the four Family A members identified 45 different 
SNPs relative to the reference sequence. Each of the SNPs were categorized so to 
distinguish potentially pathogenic SNPs from polymorphic SNPs. Firstly the SNPs were 
classified as exonic and intronic. All exonic SNPs which occur in the coding region are 
potentially pathogenic as they have the ability to change the codon and alter the peptide. 
Intronic SNPs are pathogenic only if they occur in a splice site or if they create a cryptic 
site which could prevent exons from being translated and result in termination of the 
protein. These pathogenic intronic SNPs occur most commonly at the start or the end of 
an intron, and were not the case for any of the intronic SNPs identified in this project. 
Secondly, the exonic and intronic SNPs were classified as infonnative and non-
infonnative. Informative SNPs are polymorphic, meaning alleles are different among the 
four sequenced individuals and non-informative SNPs are non-polymorphic meaning the 
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alleles do not vary amongst the four individuals. Thirdly, the exonic SNPs were classified 
a nonsynonymous and synonymous: a nonsynonymous S P causes an amino acid 
change and a synonymous SNP does not. A summary table of the number of SNPs in 
each of these categories can be found in Table 2.3. 
To test whether the CDH23 intronic SNPs affected splicing, the BDGP splice-
prediction program was used (Berkeley Drosophila Genome Project, 2004). The 9 
informative intronic SNPs were analyzed to determine if the predicted donor or acceptor 
plice site differed between the reference sequence (without the intronic SNP) and a 
sequence which included the intronic S P. o differences in splice sites were found, 
confirming that the 9 informative, intronic CDH23 SNPs are not expected to be 
pathogenic. 
The SNPs were deemed potentially pathogenic if they were exonic, infom1ative 
and nonsynonymous. Using this criterion, eight of the 45 CDH23 SNPs were potentially 
pathogenic. one of the eight potentially pathogenic CDH23 SNPs were hypothesized to 
be disease-causing because no SNP was exclusive to the deaf individuals and therefore 
no SNP segregated with deafness. This conclusion was confirmed by the literature, which 
identified all eight SNPs as non-pathogenic. In a study done by Astuto eta!. (2002), 69 
probands with Ushers syndrome and 38 probands with recessive non-syndromic deafne s 
were screened for mutations in the entire coding region of CDH23. The methods of 
heteroduplex analysis and single strand conformation polymorphism were used to screen 
for mutations, which identified numerous exonic and intronic polymorphisms. To 
determine which of these polymorphisms were pathogenic, a set of96 genetically 
independent samples of mixed European ancestry were used as a control for both 
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methods. If a mutation was found in> 1 control sample, it was considered non-
pathogenic. The eight potentially pathogenic CDH23 SNPs identified from this cun·ent 
research project are listed in the paper by Astute et al. (2002) as non-pathogenic. The 
results from this project and from the research by Astute et al. (2002) are in agreement, 
providing a level of certainty that none of the identified exonic, informative, non-
synonymous CDH23 SNPs are deleterious. 
Informative SNPs (both exonic and intronic) were used to construct the CDH23 
intragenic haplotype. The large size of the CDH23 gene (69 exons) proved useful for the 
haplotype analysis since a large number of SNPs were identified and therefore an 
informative haplotype could be constructed. Twenty-one CDH23 SNPs were u ed to 
build this haplotype, which included 12 informative exonic and 9 infonnative intronic 
S Ps (genotypes are given in Table 2.4). Only informative SNP are u eful for 
constructing haplotypes because their genotypes can be used to differentiate between 
disease-a sociated haplotypes and non-pathogenic ones. Figure 2.5 shows the constructed 
CDH23 intrageneic haplotypes segregating with the PCDH 15 mutation. 
Individual T-3 is homozygous for all identified CDH23 SNPs, meaning her 
mother and father have an identical CDH23 haplotype. It is possible that T-3 ha a 
hemizygous deletion, and she has a single copy of either the paternal or maternal CDH23 
haplotype. However, since her parents are fir t cousins there is a high possibility that they 
have passed on the same ancestral haplotype to T-3 (green haplotype, Figure 2.5). 
The haplotypes in Figure 2.5 are constructed with the PCDH15 mutation and the 
CDH23 data. According to the CDH23 data, the only expected cross-over in sib-ship 2 i 
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in T-3, between the PCDH15 gene and the CDH23 SNPc.l-88C>A. The previously 
ascertained PCDH15 data for T-3 are insufficient to confirm or rule-out this cross-over. 
The CDH23 haplotypes for T-20 and T-1 are parental (non-recombinant) in both 
siblings and no cross-over between the PCDH15 mutation and the CDH23 haplotype wa 
observed. These new CDH23 haplotypes do not agree with the previously designed 
PCDH15 haplotypes as a cross-over within the PCDH15 haplotype (after the PCDHJ 5 
mutation) was suspected in both T-20 and T-1 (Figure 2.4). Unfortunately, the original 
PCDHJ 5 data are not available to check for any potential genotyping errors. However, 
the original PCDH15 haplotypes consisted of only 7 markers (only 6 are infonnative) and 
therefore may not be accurate. Three generations of D A haplotypes and/or extensive, 
informative data from one or two generations is needed to accurately define haplotype 
boundaries. If only a single generation ofhaplotypes with limited data is avai lable, the 
haplotype boundaries are based on best a sumptions. In the sib-ship with the deaf 
heterozygotes (sib-ship 2, Figure 2.4), since no DNA is available from any other 
generation, it must be recognized that the recombinant haplotypes are based on best 
assumptions. 
By contrast, the CDH23 haplotypes are constructed based on 21 informative 
CDH23 SNPs. Furthermore, the CDH23 data has been checked numerous times for 
errors. Since the CDH23 haplotyping data is more reliable and more complete then the 
PCDH15 haplotypes, the CDH23 haplotypes constructed in Figure 2.5 and are considered 
to be the most accurate. 
The CDH23 haplotypes constructed for the three deaf Family A members in sib-
ship 2 show that each sibling has a different combination of paternal and maternal 
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CDH23 haplotypes, and that the three affecteds do not share a common CDH23 
haplotype. Since a shared CDH23 mutation was not identified, a shared CDH23 
haplotype is not expected . The differing CDH23 intrageneic haplotypes in sib-ship 2 
support the conclu ion that CDH23 does not harbour a deafness causing mutation in 
Family A. 
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Fcther Met her 
PCDH15 c.1583T>A 
COH23 c.1-88C>A T :4 
COH23 c.366T>C c c A c 
COH23 c.1487G>A T c c T 
COH23 c.1753-78A>T G A G G 
COH23 c.5023G>A T A T T G A G G COH23 c.5100C>T c T T c COH23 c.5187+44C>G c c G c COH23 c.5187+73C>T c T T c 
COH23 c.5187+99T>C c T T c 
COH23 c. 5188-128T>A T A T T 
COH23 c.5411 G>A G G A 
COH23 c.5996C>G c G G c 
COH23 c.6130G>A G G A G 
COH23 c.6847G>A G A A G 
COH23 c.7073G>A G A A G 
COH23 c.7139C>T c c T c 
COH23 c. 7225-22C> T c T T c 
CDH23 c.7572G>A G G A G 
COH23 c.9320-93C>G c c G c 
COH23 c.9380+111C>T c c T c 
COH23 c.9873G>A G G A G 
* • • 
~ 
TID T1 T3 T5 
PCOH15 c.1583T>A T A T A T A A T 
COH23 c.1-88C>A c A c A c c A c 
COH23 c.366T>C T c c c T T c T 
COH23 c.1487G>A G G G G G G G 
COH23 c.1753-78A> T T T T T T T T 
COH23 c.5023G>A G G G G G G G 
COH23 c.51 OOC> T c T T c c T c 
COH23 c.5187+44C>G c G G c c G c 
COH23 c.5187+73C>T c T T c c T c 
COH23 c.5187+99T>C c T T c c T c 
COH23 c. 5411 G>A T T T T T T T 
COH23 c.5996C>G G G A G A 
CDH23 c.6130G>A c G G c c G c 
COH23 c.6847G>A G A A G G A G 
COH23 c. 7073G>A G A A G G 
A G 
G A A G G A G COH23 c.7139C>T c T T c c T c COH23 c.7225-22C>T c T T c c T c 
COH23 c. 7572G>A G A A G G A G 
COH23 c.9320-93C>G c G G c c G c 
COH23 c.9380+1 11 C> T c T T c c T c 
COH23 c.9873G>A G A A G G A G 
Figure 2.6- CDH23 intrageneic haplotypes for selected Family A members. SNPs were identified by direct, 
automated sequencing of CDH23 in these four individuals. The yellow bar (haplotype) is the PCDH 15 
c. 1 583T>A deafness-associated haplotype. See next page for explanation. 
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Strategy used to create CDH23 haplotypes 
To accompany Figure 2.6 
I. Four members from Family A sib-ship 2 were selected for CDH23 
sequencing. All carry one copy of the PCDH15 c.1583T>A mutation. T-20, T-
1 and T-3 are deaf and T-5 is hearing. 
II. Sequencing CDH23 in these four Family A members identified 21 
informative SNPs. These SNPs were used to construct CDH23 intrageneic 
haplotypes for the four individuals. 
III. T -3 is homozygous for all identified CDH23 SNPs and therefore, her parents 
share a CDH23 haplotype (green haplotype). It is possible that T-3 has a 
hemizygou deletion, meaning only one parental haplotype is present, but since 
the parents are known first cousins, sharing is expected. 
IV. T-3 has a suspected cross-over between the PCDH15 mutation and the 
CDH23 haplotype on one chromosome. The cross-over is su pected at this 
location because it results the least number of recombinant haplotypes within the 
sib-ship. Data from PCDHJ 5 haplotypes for T-3 neither supports nor refutes this 
recombination. 
V. T-20 has two parental haplotypes and no recombinations are suspected. Thi 
is not in agreement with the previously defined PCDHJ 5 haplotypes in Figure 
2.4, as T-20 has a cross-over at DJOSJ652. It i possible that there may be a 
mistake in the PCDH15 data (original data not avai lable), or that the PCDH 15 
haplotypes could not be accurately constructed as not enough data was available. 
Since the CDH23 data is more complete and more informative, it is therefore 
more reliable. 
VI. T -1 has two parental haplotypes and no recombinations are suspected. This is 
not in agreement with the previously defined PCDH 15 haplotype in Figure 2.4, 
as T-1 has a cross-over at DJOS524. The same reasoning from T-20 can be 
applied to T-1, which concludes that the CDH23 data is more reliable. 
VII. The haplotypes for the parents of sib-ship 2 are inferred, based on the 
haplotypes of the children. The haplotyping data in sib-ship 2 i not enough to 
determine which parent segregates with the PCDH15 mutation and the CDH23 
associated haplotype. However, the PCDH 15 mutation is known to segregate on 
the maternal side. 
VIII. T -5 data does not have enough familial data available to confidently 
ascertain phase. However, as T-5 is a first cousin, some sharing can be 
expected. 
43 
29 
Exon 5 c.336T>C (Forward) Exon 39 c.5IOOC>T (Forward) 
135 
Exon 14 c.1487G>A (Reverse) Exon 41 c.541 1G>A (Reverse) 
355 ~1s . no GAM\/ 
190 
.o -- .A --
Exon 3R c. 5023G>A (Forward) Exon 45 c.5996C>G (Forward) 
Figure 2.7: Electropherograms of the 12 exonic, informative CDH23 SNPs identified 
by automated sequencing. The black arrow points to the SNP labeled in the caption. 
The reference wild-type sequence is located above or below the sample. Forward and 
reverse refers to whether the SNP has been identified by the forward or reverse p1imer. 
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-------- .... ------- -~n---
C T 0 A 0 
Exon 46 c.6130G>A (Forward) 
255 
~~r ---- A- ---- <; ---- - o- ---- -1 ----- c----- -€ 
Exon 49 c.6847G>A (Forward) 
95 -
c . c A 
Exon 50 c. 7073G>A (Reverse) 
----~ ---------~--
C---- - C . -C- -
c 
c.. 
Exon 50 c. 7139C> T (Reverse) 
100 
c G 
Exon 53 c. 7572G>A (Reverse) 
A c n c 
c 
Exon 69 c.9873G>A (Reverse) 
c 
Figure 2.7: Electropherograms ofthe 12 exonic, informative CDH23 SNPs identified 
by automated sequencing. The black arrow points to the SNP labeled in the caption. 
The reference wild-type sequence is located above or below the sample. Forward and 
reverse refers to whether the SNP has been identified by the forward or reverse primer. 
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Table 2.3: CDH23 SNPs Identified by Automated Sequencing 
Total# CDH23 SNPs Identified 45 
Infonnative, Synonymous, Exonic SNPs 4 
Informative, Non-synonymous, Exonic SNPs 8 
Non-infonnative, Exonic SNPs 4 
Total # Exonic SNPs Identified 16 
Inf01mative, Intronic SNPs 9 
Non-infonnative, Intronic SNPs 20 
Total# Intronic SNPs Identified 29 
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Table 2.4: Genotypes of Informative CDH23 SNPs Identified by Sequencing 
Mutation and protein naming is taken from Human Genome Variation Society homepage, 
June 2007. HL represents "Hearing Loss" 
Ex on Nucleotide change Theoretical T-20 T-1 T-3 T-5 
Codon change HL HL HL Control 
1 c.1-88C>A 5' untranslated region CA CA cc AC 
5 c.336T>C p.Va1122Val TC cc TT CT 
14 c. 1487 G>A p.Ser496Asp GG AG GG GG 
16 c. 1 753-78A >T intronic TT AT TT TT 
38 c. 5023G>A p.Val1675Ile AG GG AA GA 
39 c.5100C>T p.Tyr1700Tyr cc TC cc cc 
39 c. 5187+44C>G intronic CG GG cc GC 
39 c.5187+73C>T intronic CT CT cc TC 
39 c.5187+99T>C intronic TC cc TT CT 
40 c.5188-128T>A intronic AT TT AA TA 
41 c.5411G>A p.Arg1804Gln GG AG GG GG 
45 c.5996C>G p.Thrl999Ser GC cc GG CG 
46 c.6130G>A p.Glu2044Lys GA AA GG AG 
49 c.6847G>A p.Vai2283Ile GA GA GG AG 
50 c.7073G>A p.Arg2358Gin GA AA GG AG 
50 c.7139C>T p.Pro2380Leu CT TT cc TC 
51 C. 7225-22C>T intronic CT CT cc TC 
53 c. 7572G>A p.Ala2524Ala GA AA GG AG 
65 c.9320-93C>G intronic CG CG cc GC 
65 c.9380+ 11 1C>T intronic CT CT cc TC 
69 c.9873G>A p. Trp329l Trp GA GA GG AG 
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Discussion 
The objective of this study was to sequence the entire coding region and the 
exon/intron boundaries of the deafi1ess gene CDH23 to determine if it contributes to the 
unexplained cases of hearing loss in Family A. Previous work on thi family identified a 
pathogenic mutation in the deafness gene PCDH 15 which explained the deafuess in all 
fami ly members homozygous for the mutation. However in sib-ships I and 2, four deaf 
fam ily members were heterozygous for the PCDH 15 mutation; therefore, their deafuess 
was not explained by the PCDH15 mutation alone. Since the PCDH15 mutation 
explained the deafuess in Family A members who were homozygous for the mutation, it 
was expected that the PCDH15 mutation may be partially responsible for the deafuess in 
the heterozygotes. In a study published by Zheng et al. (2005), the interaction between 
single mutations in PCDH 15 and CDH23 were found to be responsible for Ushers 
syndrome (deafness, blindness) in a human child, and for non- yndromic deafness in 
mouse models. As CDH23 is located close to the previously defined deafness-associated 
haplotype which included PCDH15, it was hypothesized that a single mutation in 
CDH23, interacting with heterozygous PCDH15 mutation, might explain the deafuess in 
the unexplained siblings in sib-ship 2. Therefore, CDH23 was selected for sequencing. 
Three deaf siblings from sib-ship 2 and a hearing cousin, all heterozygous for the 
PCDH 15 mutation, were selected for sequencing. 
The study by Zheng eta!. (2005), which reported single mutations in CDH23 and 
PCDH15 as causative for deafuess in mice and Usher's syndrome in a single human case, 
is not unusual for Ushers genes. Digeneic inheritance, or double heterozygotes, has been 
repotied for other pairs of Ushers syndrome genes, including myosin VIla and hrumonin, 
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protocadherin 15 and harmonin, and cadherin23 and harmonin (Reiners et a!. 2006). Since 
the Ushers proteins are known to interact and are thought to function as a single complex 
unit, it is peculated that a dysfunction or ab ence in any one protein could disrupt the 
entire protein unit leading to the degeneration of the sensory epithelium of the inner ear, 
resulting in deafness (Reiners eta!. 2005). 
Protocadherin and Cadherin 
Cadherins are a superfamily of genes with over 80 members, which includes 
classical cadherins, flamingo cadherins, protocadherins and seven-pass transmembrane 
cadherins (Zheng et a!. 2005; Suzuki eta!. 2000). Cadherins are cell adhesion molecules 
which form gap junctions between cells, allowing cell development and regulation, 
influencing cell behaviour, and controlling cell signaling and oncogenesis (Suzuki et a!. 
2000). Recently it has been reported that cadherins play a role in the migration of 
precerebellar neuron in the caudal hindbrain (Taniguchi eta!. 2006). Characteri tic to all 
cadherin proteins is a highly conserved cadherin-specific calcium binding motif. This 
binding motif is located in the extra-cellular domain and is repeated at least five times in 
all cadherin proteins. This motifis the site of cell-cell interaction, allowing the cadherins 
proteins to adhere to other intracellular proteins. The cytoplasmic domain (C-tenninus) of 
cadherin protein is a highly conserved sequence, connected to its extra-cellular domain 
by a single trans-membrane egment (Suzuki eta!. 2000). 
Protocadherins belong in the "non-clas ical" family of cadherin . They are 
structurally unique because their cadherin-specific calcium binding motif is repeated 
more than five time and the extra-cellular domains of many protocadherins have no 
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introns (Suzuki et al. 2000). Protocadherins are required for the structure and 
organization of embryonal, neuronal and epithelial tissues during development and 
adulthood (Hampton et al. 2003). 
The protocadherin 15 protein (PCDH 15) i expressed in the inner ear, in the 
cochlea and in the retinal photoreceptors. In the cochlea, it is expre sed on the apical 
urface of the hair cells, in the supporiing cells, the outer sulcus cells and the spiral 
ganglion cells. ln the retina, PCDH 15 is expressed in the inner and outer synaptic layers 
and in the nerve fiber layer (Ahmed eta!. 2003). The human orthologue of PCDH 15 
spans 1.6Mb on chromosome 10q2l.l , has 33 exons, 1955 amino acids, and ha a 
molecular weight of 216kD. The stari codon, located in the middle of exon 2, is at 396bp 
and the stop codon, located in exon 33 is at 6,263bp (Online Mendelian Inheritance of 
Man, 2006). Mutations in the PCDH15 gene have been found mostly to cause syndromic 
deafness (USH I F), but at least one case of autosomal recessive non-syndromic deafness 
has been reporied (Ahmed et al. 2003). The mouse model is the A me waltzer, which 
presents with deafness, circling behaviour and head tossing due vestibular imbalance. 
The stereocilia (hair cells) in its inner ear are disorganized and there is degeneration of 
the inner ear neuroepithelia (Hampton et al. 2003). 
Cadherin23 (CDH23) is a protein from the cadherin family. It is expressed in both 
sensory hair cells and in Reissner's membrane of the inner ear (Reiners et al. 2000). The 
protein has a short intracellular domain, a single-pass trans-membrane domain which 
contains a 27-repeat of the cadherin-specific calcium binding motif(Reiners et al. 2000). 
The CDH23 gene has 69 exons, including two micro-exons, spans 300kB, and codes for 
3354 amino acids (Bolz et al. 2001). Mutations in CDH23 causing non-syndromic and 
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syndromic deafness have been well documented (deBrouwer eta!. 2003, Bolz eta!. , 
200 1). 
SNPs Identified by Sequencing CDH23 
The deafness gene CDH23 was sequenced in four Family A members to 
dete1mine if a mutation in this gene contributed to deafness in the deaf individual which 
could not be explained by the PCDH15 mutation. A total of 45 distinct CDH23 SNPs as 
compared a CDH23 reference sequence were identified in the four individuals. The SNPs 
were categorized to differentiate polymorphic from potentially pathogenic SNPs. This 
was done by first sorting the SNPs into exonic and intronic SNPs. Intronic SNPs are 
pathogenic only if they occur in a splice site or if they create a cryptic site. A variant in 
the splice site could prevent exons from being translated, which could result in 
termination of the protein. These pathogenic intronic SNPs occur most commonly at the 
start or the end of an intron, and were not the case for any of the intronic SNPs identified 
in this project 
The intronic and exonic CDH23 SNPs were classified as informative and non-
informative, and the informative exonic SNPs were classified as synonymous and non-
synonymous. Eight of the CDH23 SNPs are exonic, infonnative and non-synonymous, 
and were considered potentially pathogenic. However, none of these SNPs co-segregated 
with deafness. These eight potentially pathogenic CDH23 SNPs are listed in the paper by 
Astuto eta!. (2002) as non-pathogenic, confirming that no mutation in CDH23 is 
suspected to be pathogenic. 
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Twenty-one infonnative SNPs (12 exonic and 9 intronic) were used to con truct 
the CDH23 intrageneic haplotype. No CDH23 intrageneic haplotype was shared by all 
three Family A members with hearing loss; all three had a different combination of 
paternal and maternal CDH23 haplotypes. This finding is in agreement with the 
conclusion that no CDH23 S P is suspected to be pathogenic. 
Possible Explanations for Genetic Cause of Deafness in Family A 
Given the evidence supporting CDH23 as a potential candidate gene, it is 
somewhat urprising that we did not identify a pathogenic mutation in CDH23. A 
number of possibilities exist which could explain the deafness in this sib-ship. Firstly as 
the deafnes phenotype in sib-ship 2 differs in onset from other deaf Family A members, 
the deafness in thi sib-ship may have a different genetic cause. A possibility is that the 
PCDH15 mutation may not be contributing to the deafness in these family members, and 
is only present by coincidence. The deaf persons in sib-ship 2 could be homozygous for a 
mutation in a yet-to-be-identified gene. A genome-wide scan on this sib-ship would yield 
important data relative to this possibility; however using this sib-ship alone for a GWS 
may not be powerful enough to identify the causative gene. 
A second possibility is that a gene re iding within the deafness-associated 
haplotype, not yet classified as a deafness gene could be contributing to the deafness. 
However, a revision of all the genes within the deafness-associated haplotype region did 
not reveal any genes, functional or otherwise, which seemed to have deafness-causing 
potential. It is of note that although the genome has been mapped, not all genes have been 
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annotated (identified). Therefore, the di ease-causing gene may reside within the 
deafness-associated haplotype, but cannot be identified because it has not been annotated. 
A third possibility is the deafness in sib-ship 2 may have an environmental cause, 
such as the measles or mumps and the PCDH 15 mutation may not be contributing to the 
deafness. A review of the dates of outbreaks of hearing-related disease such as measles in 
Newfoundland would help address this possibility. It is the author's opinion that the 
deafness in this sib-ship may have an environmental cause, as the majority of the siblings 
are affected. The mutation in PCDH15 may be coincidental, and these siblings may be 
phenocopies. 
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Conclusion 
This study was conducted to detennine if CDH23 contributed to deafuess in 
Family A. Sequencing the entire coding region of CDH23 and all exon/intron boundaries 
in tlu·ee deaf family members and a hearing fam ily member did not identify any CDH23 
mutations. Initially, eight of the identified CDH23 SNPs were suspected to be pathogenic 
because they were located in the coding region (exon) and were polymorphic. However 
they have since been classified as non-pathogenic because the SNPs did not segregate 
exclusively with deafuess and all eight SNPs were documented by Astuto eta!. (2002) a 
non-pathogenic. 
Initially, CDH23 seemed to be a promising candidate gene because of its 
proximity to the previously identified deafness-associated haplotype and due to it known 
interaction with PCDH15. However, the results from this study how that CDH23 does 
not contribute to the deafness in Family A. 
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Chapter 3: Family Band Family 41 
Introduction 
Family History on Family B 
Family B is a large deaf family, originating from a small community on the 
Southwest coast of Newfoundland. The complete pedigree document 229 family 
members, spans seven generations and reports 14 cases of inbreeding. Twenty family 
members have been diagnosed with autosomal recessive, non-syndromic hearing loss. 
Figure 3.1 is a partial pedigree of Family B. 
An extensive genealogy dating back to the family's founders has been collected 
by a present-day family member of Family B. The founder male was born in the early 
1800s and was from England, and the founder female, also born in the early 1800s, 
otiginated from a small community on the Southwest coast of Newfoundland. They were 
wed in 1822 and had five children. The genealogy extends from its founders to its 
members in the present-day generation. It is a very complete pedigree, documenting most 
of the family names as well as extended family members who mani.ed into the family 
over the past 200 years. In all , more than 500 family members have been identified. The 
family hi tory (names, birth dates, etc.) ascertained through this (independent) genealogy 
agrees with the data collected through the Newfoundland Medical Genetics Program, 
providing a level of verification of both data sets. The Newfoundland Medical Genetics 
Program ha been collecting demographic information, birth measurements (weight, 
gestation), and birth defect diagnostic infonnation from all live births occurring in the 
province since 1976. This infonnation can be accessed for the purpose of research. 
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A study performed by Bear et a!. ( 1987) compared the genetic relatedness of 
persons from ewfoundland communities at variou distances. The findings reported that 
people from the same community and from communities in close proximity had a higher 
degree of genetic relatedness compared with people from communities which were more 
distant. Genetic relatedness was measured by using the average kinship coefficient (the 
probability that an allele selected at random will be identical in two individuals because it 
was inherited from a common ancestor). Most of the 500 family members in Family B 
are from one of three outports situated very close to each other along ewfoundland's 
Southwest coast. Therefore, it can be suspected that these family members, even those 
who manied into the family, will have a high degree of relatedness. 
Previous Research on Family B Identified TMPRSS3 as Deafness-Causing Gene 
Family history and DNA collection on Family B were performed by Dr. E. Ives 
(Newfoundland Medical Genetics Program). The information and the D A samples were 
given to the Edward Wilcox laboratory in Rockville, MD, in an effort to identify the 
causal disease gene. A genome-wide scan was performed, which identified linkage to 
markers at the DFNB8/B I 0 locus in one branch of the pedigree (Ahmed et al. 2004). The 
deafness gene Tempress3 (TMPRSS3) resides at the locus of DFNB8/B I 0. The haplotype 
analysis of the linked markers at the DFNB8/ B I 0 locus demonstrated homozygosity. 
Consequently, a deafness-associated haplotype was constructed. Family B members who 
carried at lea tone copy of the deafness-associated haplotype were sequenced in ful l for 
TMPRSS3. Two pathogenic alleles were identified by this sequencing. One of the e 
pathogenic alleles, c.207delC in exon 4, is a known mutation, and has been described in 
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the Spanish, Greek and Pakistani populations (Ahmed et al. 2004). This mutation 
produces a frameshift in the reading frame of the translated DNA sequence, and is 
predicted to produce a protein which is missing three of the four conserved domains 
(Wattenhofer et al. 2002). The second identified TMPRSS mutation is a novel mutation, 
designated c.782+3delGAG, and occurs at the splice site between intron 8 and exon 9. 
This splice-site mutation is predicted to splice out up tream exons and may produce a 
prematurely terminated TMPRSS3 protein (Ahmed et al. 2004). 
All Family B members who carried two copies of the TMPRSS3 c.207delC 
mutation were deaf (persons 260, 246 and 249 in Figure 3.1 ). Two deaf siblings (291 and 
285 in Figure 3.1) were heterozygous for the c.207deiC mutation and also heterozygous 
for the novel c.782+3delGAG mutation. o hearing per on was heterozygous for both 
mutations and no family member homozygous for the c.782+3delGAG mutation was 
identified. The two heterozygous mutations in TMPRSS3 were identified as the cause of 
deafness in the deaf iblings. The genetic term for two single mutation in the same gene 
acting together to produce a disease phenotype is called compound heterozygosity; the 
two deaf siblings with the two TMPRSS3 mutations are called compound heterozygotes. 
Recently, another case of compound heterozygosity in TMPRSS3 has been identified as 
the cause of pre-lingual deafness in four Gennan children (Eibracht et al. 2007). These 
findings on Family B were published by Ahmed et al. (2004). Although two TMPRSS3 
mutations were identified as causal for deafness, Ahmed et al. (2004) reported only a 
single mutation TMPRSS3 haplotype and suggested this haplotype mutated twice. 
However, it is more likely that two TMPRSS3 haplotype exist, each mutation 
segregating with its own haplotype. The en·or in the Ahmed et al. (2004) seems to be how 
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the TMPRSS3 haplotype was constructed. A careful analysis by this author found that the 
data from the Ahmed et al. 2004 contained too few markers and the markers which had 
used were non-polymorphic genotypes (non-infmmative). Consequently, the resulting 
TMPRSS3 haplotype was not characte1ized enough. In this project, additional markers 
and polymorphic TMPRSS3 SNPs will be used to more fully map the TMPRSS3 
haplotype in selected fami ly members to detennine if two mutated TMPRSS3 haplotypes 
exist in Family B. 
Family History of Family 41 
A mutation screen on the 48 ascertained deaf probands from the Newfoundland 
population was recently performed (Gamberg, personal communication). The probands 
were screened all known Newfoundland deafness mutations (one in WFSJ, 2 in 
TMPRSS3,and one in PCDH15) and the two common connexin mutations (GJB2 and 
GJB6). The proband in Family 41 was identified as a heterozygous carrier of the 
TMPRSS3 c.782+3delGAG mutation, previously identified in Family B. Subsequently, 
the entire TMPRSS3 gene (13 exons) was sequenced in the proband, his father and his 
mother (who was also heterozygous for the mutation but was hearing). No other 
TMPRSS3 mutations were found (Gamberg, personal communication). Since the novel 
TMPRSS3 c.782+3delGAG mutation is present in two unrelated fami lies in a founder 
population, it was hypothesized that this mutation may be a Newfoundland founder 
mutation. 
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Goal for Family B 
To detennine ifthe two TMPRSS3 mutations, c.207delC and c.782+3delGAG, egregates 
on separate mutation haplotypes. 
Goal for Family B and Family 41 
To determine if the c.782+3delGAG TMPRSS3 mutation, identified in both Fami ly Band 
Family 41, occurs on the same haplotype. 
Objectives 
1. Find informative (polymorphic) markers and TMPRSS SNPs within the 
boundruies of the previously defined TMPRSS3 deafness-associated haplotype [as 
defined by Ahmed et al. (2004)] 
2. Genotype the Famil y B compound heterozygotes and their immediate frunily 
members and construct the TMPRSS3 haplotypes flanking each TMPRSS3 
mutation. Detennine if the two TMPRSS3 mutations occur on separate haplotypes. 
3. Genotype the chromosomal area flanking TMPRSS3 in the proband and mother in 
Family 41 using the infonnative markers and TMPRSS3 SNPs and construct the 
haplotypes. 
4. Compare the TMPRSS3 c.782+3delGAG mutation haplotype in can·iers in Frunily 
B and Family 41. If the haplotypes are identical, it is evidence this mutation is a 
founder mutation and the haplotype is a founder haplotype. 
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303 259 
E41+ E41+ 
250 251 
E41+ 
312 260 256 246 249 291 .286 285 2El 
E41+ E41E4 E41+ E41E4 E41E4 E4118 E41+ E4118 +I+ 
311 323 298 
+I+ E41+E41+ 
Figure 3.1 - Partial pedigree of Family B showing carrier status for TMPRSS3 exon 
4 mutation (E4) and the TMPRSS3 intron 8 mutation (18). The affecteds (black 
symbol) are diagnosed with severe-profound, non-syndromic, autosomal recessive 
hearing loss. Two sibs (29 1, 285) are compound heterozygotes for the TMPRSS3 exon 4 
mutation and the TMPRSS3 intron 8 mutation. The + symbol indicates the per on is wi ld-
type for the mutation. 
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RB04-100 
181+ 
Figure 3.2 - Partial pedigree of Family 41 showing the identified carriers of the TMPRSS3 intron 8 mutation (18). The proband (RB04-1 00) 
and his unaffected mother (DB04-99) are heterozygous for the mutation (18/+) and the proband's father (LB04-90) is wild type (+/+). DNA for other 
family members is not available. RB04-l 00 has a hearing loss in the right ear only (denoted by right side of symbol shaded). 
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Methods 
Subject Recruitment 
Family members for Family B were recruited through the Newfoundland Provincial 
Genetics Program, which was initiated in 1988 by Dr. E Ives. Family 41 was recruited 
through a province-wide program aimed at recruiting all Newfoundlander with 
hereditary sensorineural hearing loss. Most Newfoundland health care professionals who 
provide specific services to the deaf and the hearing impaired are involved with this 
program. Research participants were required to give infonned consent and donate a 
sample of blood. A signed consent form granted permission to access medical records 
and family history. Audiological tests were performed by a local physician to detennine 
the type of hearing loss of affected individuals and to confinn nonnal hearing in non-
affected persons. Physical exams (also performed by a local physician) were perfonned 
to determine whether affected persons were affected with other conditions (ie. syndromic 
hearing loss). Vision and vestibular function were performed to test for U hers 
syndrome. This project was approved by the Human Investigations Committee (HIC), 
Research Ethics Board of Memorial University, Newfoundland and Labrador(# 01 .186). 
DNA Preparation, PCR Thermo-cycling, and Electrophoresis 
See Chapter 2, Methods, page 34 
Protocol for Genotyping 
A volume of0.5)..LL of diluted PCR sample (I :10), 9)..LL ofDMF and 0.4)..LL of 
Sequencing Size Standard was added to each reaction well in an optical plate. The 
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samples were denatured using a thennocycler, and were transferred immediately to the 
ABI 3130 for genotyping. Thermocycling conditions required for denaturing are found 
under Methods section in Chapter 2. The PCR products from the fluorescently labeled 
primers were detected by an ABI 3130 Genetic Analyzer (Applied Biosystems, Foster 
City, CA) and genotyped u ing GeneMapper Software (ABI Prism, Version 3.5). The 
TMPRSS3 haplotypes in Figure 3.3 and 3.4 were created manually and not by use of a 
computer program. 
Markers and SNPs used to Construct the New TMPRSS3 Haplotypes 
The markers used to construct the TMPRSS3 haplotypes were selected from Genome 
Browser (University California Santa Cruz, 2006). The marker heterozygosi ty was 
selected at ?:.0.7 to maximize polymorphism. Marker heterozygosity is the chance a 
randomly selected person will be heterozygous for that marker. Table 3.2 is a list of 
microsatellite markers used to characterize the TMPRSS3 exon 4 and intron 8 mutation 
haplotypes. The markers were selected based on location as well as heterozygosity; 
selected to be spaced - 1 Mb apart, starting from I OMb proximal of the TMPRSS3 gene 
and finishing at the end of the chromosome. 
Table 3.3 is a list of the TMPRSS3 SNPs used to characterize the two TMPRSS3 
mutation haplotypes. The TMPRSS3 SNPs were identified through a different project 
which sequenced the entire TMPRSS3 gene in all the Newfoundland deaf proband to 
identify any potentially pathogenic mutations (Gamberg, personal communication). The 
TMPRSS3 SNPs selected to construct the TMPRSS3 haplotype were highly polymorphic. 
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Family Members Selected for Genotyping 
Five individuals from Family 8 were selected for TMPRSS3 haplotyping, including the 
two deaf compound heterozygotes (291 and 285), their parents (288 and 290), and their 
unaffected ister (286) (Figure 3.1). Three individuals from Family 41 were haplotyped 
for TMPRSS3 including the heterozygous proband (RB04-l 00), his unaffected mother 
(0804-99, who was also heterozygou for the mutation) and his unaffected father (LB04-
90) (Figure 3.2). Table 3.1 is a summary of the audiology reports and TMPRSS3 mutation 
status from selected Family B members and the three Family 41 members. 
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Results 
Figure 3.3 shows the results from haplotyping the area flanking the TMPRSS3 
exon 4 mutation in selected Family B members. The TMPRSS3 exon 4 mutation 
haplotype originates from the father (290) and is inherited by the two compound 
heterozygotes (291 and 285) and the unaffected daughter (286). Their mother does not 
carry the exon 4 mutation and consequently does not share the TMPRSS3 exon 4 
mutation haplotype. It can be reasonably assumed the other TMPRSS3 exon 4 mutation 
caiTiers in Family B share the same mutation haplotype. 
Figure 3.3 also shows the results from haplotyping the TMPRSS3 intron 8 in 
Family B. The data from the additional markers and TMPRSS3 SNPs provides evidence 
that two mutated TMPRSS3 haplotypes are present in Family B. As mentioned, the 
TMPRSS3 exon 4 haplotype has been inherited from the father - an immediate fami ly 
member in Family B. The two compound heterozygotes (291 , 285) have inherited the 
TMPRSS3 intron 8 mutation and mutated haplotype from the mother (288), who has 
married into Family B. No other Family B members have been identified as carrying the 
TMPRSS3 intron 8 mutation (Figure 3.1). The TMPRSS3 intron 8 mutation does not seem 
to OI;ginate from Family B; rather it is only present in one branch of the pedigree, 
brought into the family through maniage. 
Figure 3.4 shows the TMPRSS3 intron 8 haplotypes in Family 4 1. The deaf 
proband (RB04-100) has inherited the TMPRSS3 intron 8 mutation (and TMPRSS3 intron 
8 mutation haplotype) from his unaffected mother (DB04-99). His father (LB04-90) is 
not a carrier. 
65 
The TMPRSS3 intron 8 haplotype identified in Family B is identical to the 
TMPRSS3 intron 8 haplotype in Family 41 (ie. the catTiers share a span of alleles which 
flank the TMPRSS3 intron 8 mutation). Table 3.4 outlines which alleles are shared among 
the caniers and the total span of DNA which is shared. Since family members in Family 
B and Family 41 share a common haplotype and a common disease mutation, the 
haplotype can be considered a founder haplotype and the mutation is a founder mutation. 
It is quite possible these families have a recent common ancestor. 
66 
D 
290 288 
D21S1413 173 173 173 173 
D21S1920 222 222 222 228 
021S1252 232 246 240 246 
D21S1255 111 121 109 119 
021S1893 112 112 112 112 
D21S266 156 156 156 168 
TMPRSS3 c. 157G>A A G G G 
TMPRSS3 c. 207de/C E4 + + + 
TMPRSS3 c. 447-13 A>G G A A A 
TMPRSS3 c.453 G>A G A A A 
TMPRSS3 c. 782+3de/GAG + + E8 + 
TMPRSS3 c.1365+2G>A G A G G 
D21S1411 269 305 285 301 
D21S1259 216 214 214 214 
D21S1897 201 203 201 203 
D21S1446 210 222 210 210 
291 286 285 
D21S1413 173 173 173 173 173 173 
D21S1920 222 222 222 228 222 228 
D21S1252 232 240 232 246 246 240 
D21S1255 111 109 111 119 111 109 
D21S1893 112 112 112 112 112 112 
D21S266 156 156 156 168 156 156 
TMPRSS3 c. 157G>A A G A G A G 
TMPRSS3 c. 207de/C E4 + E4 + E4 + 
TMPRSS3 c. 447-13 A>G G A G A G A 
TMPRSS3 c.453 G>A G A G A G A 
TMPRSS3 c. 782+3de/GAG + E8 + + + E8 
TMPRSS3 c.1365+2G>A G G G G G G 
D21S1411 269 301 269 301 269 285 
021S1259 216 214 216 214 216 214 
D21S1897 201 203 201 203 201 201 
021S1446 210 210 210 210 210 210 
Figure 3.3- TMPRSS3 exon 4 and TMPRSS3 intron 8 mutation haplotypes in two compound 
heterozygotes (291, 285), their unaffected sib (286) and two unaffected parents (290, 288) from 
Family B. The light blue bar is the TMPRSS3 exon 4 haplotype, inherited from the paternal side (Family 
B) and carried by all three sibs. The dark blue bar is the TMPRSS3 intron 8 haplotype, inherited from the 
maternal side (not direct member of Family B) and only present in the compound heterozygotes. Per on 
291 has a suspected cross-over on the TMPRSS3 intron 8 haplotype at D21Sl411. Per on 285 has two 
recombinant haplotypes: the crossing-over occurs at D2IS1255 on the TMPRSSS3 exon 4 haplotype and 
at D21Sl920 on the TMPRSS3 intron 8 haplotype. All markers and SNPs are taken from Markers are 
taken from Genome Browser (University California Santa Cruz, 2006). 
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LB04-90 0804-99 
021S1413 173 
021$1920 222 
021$1252 238 
021$1255 113 
021$1893 110 
021S266 168 
TMPRSS3 c. 157G>A G 
TMPRSS3 c.207de/C + 
TMPRSS3 c. 447-13 A>G G 
TMPRSS3 c.453 G>A G 
TMPRSS3 c. 782+3de/GAG + 
TMPRSS3 c.1365+2G>A A 
021$1411 305 
021$1259 216 
021$1897 199 
021$1446 210 
021$1413 
021S1920 
021$1252 
021$1255 
021$1893 
021S266 
TMPRSS3 c. 157G>A 
TMPRSS3 c. 207de/C 
TMPRSS3 c.447-13 A>G 
TMPRSS3 c.453 G>A 
TMPRSS3 c.1365+2G>A 
021$1411 
021$1259 
021$1897 
021$1446 
173 181 
228 228 
240 240 
109 109 
112 112 
156 156 
G G 
+ + 
G A 
G A 
+ E8 
G G 
285 285 
214 214 
201 201 
226 210 
RB04-100 
173 181 
222 228 
238 240 
113 109 
110 112 
168 156 
G G 
+ + 
G A 
G A 
+ E8 
A G 
305 285 
216 214 
199 201 
210 210 
169 
218 
246 
119 
110 
156 
G 
+ 
G 
G 
+ 
G 
293 
218 
199 
214 
Figure 3.4 - TMPRSS3 intron 8 haplotypes for affected proband (RB04-100) and unaffected 
mother (DB04-99) in Family 41. The father (LB04-90) is not a carrier of the TMPRSS3 intron 8 
mutation. The TMPRSS3 intron 8 haplotype is highlighted in blue to show the common alleles with the 
carriers of the TMPRSS3 intron 8 haplotype in Family B. Markers are taken from Genome Browser 
(University California Santa Cruz, 2006). 
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Marker/ 
TMPRSS3SNP 
021$1413 
36418979 021$1920 
36 748 729 021$1252 
38 716 581 021$1255 
40 278 209 021$1893 
41 606 427 021$266 
42 665 226 TMPRSS3 157G>A 
42 665 376 TMPRSS3 c.207de/C (E4) 
42 665 503 TMPRSS3 c.447-13A>G 
42 665 522 TMPRSS3 c.453G>A 
42 665 854 TMPRSS3 c. 782+3de/GAG (18) 
42 666 435 TMPRSS3 c.1365+2G>A 
43 033 713 021$1411 
44 148 293 021$1259 
45 369 052 021$1897 
46 862 011 021$1446 
Figure 3.5: TMPRSS3 intron 8 Haplotype Identified in Family B and Family 41 Members. 
Family B members 288 and 285 share a span of - 10.12 Mb with Family 4 1 members DB04-99 
and RB04-l 00. This hared haplotype includes 8 markers, 5 TMPRSS3 SNPs and one TMPRSS3 
mutation (intron 8) and is located on chromo orne 21 q22.3. The green region highlights the shared 
alleles. 
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Figure 3.6 - Examples of Genotypes for Marker D21S1920 (GeneMapper). 
Homozygosity or heterozygosity of a marker is detennined by the number of times a 
band pattern is present (ie. the pattern of vertical peaks, in this case green). If the band 
pattern is present only once, the person is a homozygote (ie. 290); if the band pattern is 
present two times, the person is heterozygous (ie. DB04-99).The nwnbers in the boxes 
under the band pattern are the genotypes, or alleles. For example, 290 is homozygous 
(222,222) and RB04-1 00 is heterozygous (222,228) for marker D2 1 SJ920 . . 
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Table 3.1: Summary of Audiology Reports from Selected Members from Family B and Family 41 
Ped # Fami Gender Type of Hearing Loss TMPRSS3 Mutation ly 
246 B M profound, bilateral sen orineural hearing loss 
E4/E4 
247 B F none E4/+ 
249 B M profound, bilate ra l sensorineural hearing loss E4/E4 
250 B F none E4/+ 
25 1 B M none E4/+ 
256 B F none E4/+ 
259 B M none E4/+ 
260 B F profound, bilate ra l sensorineural hearing loss E4/E4 
285 B M profound, bilate ra l sensorineural hearing loss E4/18 
286 B F none E4/+ 
287 B M none "+/+" 
288 B F none 18/+ 
289 B F none E4/+ 
290 B M none E4/+ 
29 1 B M profound, bilate ra l sensorineural hearing loss E4/18 
295 B F none -
296 B M m i lcllmoderate/severe II+/+" 
297 B M none "+/+" 
298 B F none E4/+ 
303 B F moderate in RE E4/+ 
31 1 B M none "+/+" 
3 12 B F none E4/+ 
323 B F none E4/+ 
DB04-99 4 1 F none 18/+ 
LB04-90 41 M none "+/+tl 
RB04-100 41 M mod/severe in RE 18/+ 
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Table 3.2: Microsatellite Markers used to Build the TMPRSS3 Haplotypes 
Genome Browser (University California Santa Cruz, 2006) 
Marker Location On 21q22.3 Microsatellite Heterogeneity Product 
Size 
Mapped from the Repeat Type (>0.7) (bp) 
Centromere (bp) 
D21S1413 32 769 678 Tetrenucleotide 0 .875 160-200 
D2JSJ920 36 418 979 Dinucleotide 0.740 220-234 
D21S1252 36 748 729 Dinucleotide 0 .804 23 1-251 
D21S1255 38716581 Dinucleotide 0.803 I 00-140 
D21Sl893 40 278 209 Dinucleotide 0 .760 100-130 
D21S266 41 606 427 Dinucleotide 0.604 140-180 
D21S1411 43 033 713 Tetranucleotide 0.933 220-250 
D21Sl259 44 148 293 Dinucleotide 0 .670 200-240 
D2JS1897 45 369 052 Dinucleotide 0.740 188-214 
D2JSJ446 46 862 011 Tetrenucl eo tide n/a 200-240 
72 
Table 3.3: TMPRSS3 SNPs used to Create the TMPRSS3 Exon 4 and Intron 8 Haplotypes 
TMPRSS3 Sequencing_ SNPs Exon/Intron Reference Pathogenic 
TMPRSS3 157G>A Exon 3 Scott, 2001 no 
TMPRSS3 207delC Exon4 Wattenhofer, 2002 yes 
TMPRSS3 447-13A>G Intron 5 Wattenhofer, 2002 no 
TMPRSS3 453G>A Exon6 Scott,2001 no 
TMPRSS3 782+3de/GAG Intron 8 Ahmed, 2004 yes 
TMPRSS31365+2G>A Exonl3 Scott, 200 1 no 
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Discussion 
Family B is a large, consanguineous family from the Southwest Coast of 
Newfoundland. Twenty family members have been diagnosed with non-syndromic, 
autosomal hearing loss. In 2004, work perfonn ed by the Wilcox lab determined the cause 
of deafness in Family B was due to two mutations in TMPRSS3: c.207delC in exon 4, a 
known mutation, and c.782+3deiGAG in intron 8, a novel mutation (Ahmed et at. 2004). 
Most of the deaf family members were homozygous for the c.207delC mutation, but two 
deaf siblings (291 and 285, Figure 3.1) were heterozygous for the c.207delC mutation 
and the c. 782+ 3delGAG mutation. The cause of their deafness wa explained by the 
interaction of these two single mutations in TMPRSS3, called compound heterozygosity. 
The paper published on this work (Ahmed et at. 2004) reported the two TMPRSS3 
mutations had occurred on the one haplotype and that the "founder haplotype" had 
mutated twice. This is an unlikely scenario however, as the DNA mutation rate (in the 
human species) is generally low (Strachan and Read 1999). It was hypothesized only one 
mutation haplotype was found was because not enough infonnative markers were used. 
One of the goals of this cun·ent project was to more create a more complete TMPRSS3 
haplotype using more infonnative markers and TMPRSS3 SNPs to determine if a second 
mutated haplotype ex ists in Family B. 
The results from haplotyping the two TMPRSS3 mutations with the additional 
markers and TMPRSS3 SNPs in selected Family B members provided evidence that two 
distinct TMPRSS3 mutation haplotypes exist , and that each mutation segregates with its 
own haplotype (Figure 3.3). It is suspected that Ahmed et at. (2004) did not use enough 
infonnative markers/SNPs so that the second haplotype was mi sed. 
74 
------~ ---- -
During the process of a mutation screen of all the deaf Newfoundland pro bands, 
the proband from Family 41 and his unaffected mother were found to carry a single copy 
of the TMPRSS3 c.782+3delGAG intron 8 mutation, the same mutation identified in the 
compound heterozygotes in Family B. Both parents in Family 41 01iginated from the 
Burin Peninsula (NL). It was suspected that this mutation may be a founder mutation, 
and that the c.782+3delGAG TMPRSS3 mutation wa passed on to both famili es from a 
recent common ancestor. The second goal in this study was to determine if the TMPRSS3 
c. 782+ 3delGAG is a founder mutation. This was determined by comparing the TMPRSS3 
intron 8 mutation haplotypes (c.782+delGAG mutation) in carriers in Family 41 and 
Family B to detennine if the haplotype is identical. 
The TMPRSS3 intron 8 mutations haplotypes in mutation carriers in Family B 
and Family 41 are identical. As shown in Figure 3.5, two Family B members (291 , 285) 
and two Family 41 members (RB04-I 00, DB04-99) share a span of 10.1 Mb of DNA, 
which includes 8 informative markers, 5 infonnative TMPRSS3 SNPs, and the TMPRSS3 
intron 8 mutation. This is sufficient evidence to conclude that the haplotype is a founder 
haplotype, the intron 8 mutation is a founder mutation, and that the two families are 
related through a recent, common ancestor. 
It is possible that this common ancestor may be one of Newfoundland ' s first 
settlers. If this is true it would be expected that there would be a high catTier rate of the 
c.782+3delGAG founder mutation in the Newfoundland population. 
To date, it is not known how Family Band Family 41 are related. Family B is 
from the Southwest coast, and Family 41 is from the Burin Peninsula. It is important to 
recognize that the origin of the TMPRSS3 intron 8 mutation in Family B is the mother 
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(288) who ha man·ied into the family (the only other Family B member who have the 
mutation are her children, 291 and 285). Therefore, in order to identify a common 
ancestor of the mutation carriers in Family B and Family 41, it i important that the 
family of the caiTier mother (288) in Family B be researched. To date, the only family 
hi tory available on the carrier mother is that h originates from the same community as 
Family B. 
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Future Directions for Research on Family Band Family 41 
Further work is needed to fu lly solve the genetic deafness in Family 41 . To date, 
the only mutation identified in the family is the TMPRSS3 intron 8; as the deafness 
segregates in an autosomal recessive pattern, the deaf proband must harbour a second 
mutation. He has already been screened for all ewfoundland deafness mutations and 
sequenced the remaining TMPRSS3 exons but a second mutation has not been found 
(Gamberg, personal communication). The only DNA available for Family 4 1 is on the 
proband and his parents. The pedigree for Family 4 1 shows that both parents have deaf 
relatives. If the DNA from these relati ves could be collected, linkage analysis could be 
performed which might identify the second gene which explains the deafness in the 
probands and identi fy a novel deafness gene. However, it must be noted that his heating 
lo s occurs in only one ear, which is an atypical phenotype compared with others in his 
family and it is possible that he is a phenocopy. If th is is the case, the resul ts from linkage 
analysis would be skewed. 
Although not discussed in thi s thesis, Family B has a number of deaf fami ly 
members who could not be fully explained. The majority unexplained are affecteds who 
are heterozygous for the TMPRSS3 exon 4 mutation; as well, number are wild-type for 
both TMPRSS3 mutations. A follow-up for Family B could be to re-exami ne the resul ts 
from the previously genome-wide scan to determine if there is a second significant LOD 
score which could point to the locus of a second mutation. 
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Conclusion 
Previously, Family B was studied to detennine the genetic cause of deafhess. Two 
mutations in the deafuess gene TMPRSS3 were identified as causal but only one mutation 
haplotype was defined. The current project used additional informative markers and 
polymorphic TMPRSS3 SNPs to generate more informative TMPRSS3 haplotypes. With 
the additional data, it was found that two distinct TMPRSS3 mutation haplotypes exist in 
Family B which segregate independently with the two mutations. These TMPRSS3 
mutation haplotypes can be used in the future to compare with other identified TMPRSS3 
mutation carriers in the Newfoundland population. 
Subsequently, a deaf individual from Family 41 and his unaffected mother were 
identified as heterozygotes for the TMPRSS3 intron 8 mutation, the same mutation as 
identified in Family B. The TMPRSS3 intron 8 mutation was haplotyped in the carriers in 
Fami ly 41 using the same markers and TMPRSS3 SNP as used in Family B. It was found 
that two mutation calTiers of the TMRPSS3 mutation in Family B and two mutation 
ca1Tiers in Family 41 share a common TMPRSS3 intron 8 mutation haplotype which 
spans 10.1 Mb and includes 8 markers, 5 SNPs and the intron 8 mutation. This suggests 
that the TMPRSS3 intron 8 mutation is a founder mutation and its ' haplotype is a founder 
haplotype. Furthermore, it is quite possible that Family 8 and Family 41 are related 
through a common ancestor. Further work is needed to determine how the two families 
are related. 
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Appendices 
Appendix A: How to Genotype using Radioactive Samples. How to Read a 
Genotyping Gel 
DNA was extracted from whole blood using common procedure. Using the 
forward and reverse primers and a cocktail of appropriate buffers and enzymes, the DNA 
region of interest was isolated and amplified on an automated thennocycler ( ee Methods 
ection, Chapter 1 ). A radioactive nucleotide ( dGTP) was added to the dNTP mix in 
place of an inert dGTP, as a means of radioactive labeling. The amplified, radioactive 
PCR product was run on a 6% acyrilamide gel (slab gel). The time needed to run the 
samples on the gel depended on the base pair fragment length of the PCR products 
(smaller base pair fragment, shorter length of time). 
A sheet of white corrugated paper was placed on the finished gel to transfer the 
radioactive product , and then peeled away from the gel. The corrugated paper was then 
placed in a cas ette containing a film negative for a few days, exposing the radioactive 
samples to the film. The PCR products could then be visualized using a light box with the 
film negative. 
The PCR products on the film negative appear as staggered bands running down 
vertically, which are differentially shaded. The various shading corresponds to different 
alleles. The darkest bands are the true alleles, while the lighter bands are "shadow 
bands" - bands which migrate with the true alleles. Each marker amplifies a particular 
pattern of alleles, consisting of dark bands (true alleles) and shadow bands. A 
homozygote will have one clear pattern of bands. A heterozygote will have two copies of 
the band pattern which may be spaced apart from each other, making the two copies very 
86 
obvious, or they may overlap, so that the patterns are hard to distingui h. Related per ons 
will share the same pattern of bands; for example a child will have a band pattern 
inhelited from hi mother and another inherited from his father. 
The highe t dark band (also the highest molecular weight) i numbered I , and the 
bands further down are numbered sequentially. Thi process is termed genotyping. 
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Appendix B: Deafness genes identified in the Newfoundland population (Gamberg, 
personal communication) 
Mutation Amino acid #NL Lit 
Name change Families Reference 
GJB2/CNX26 35de!G Truncation 7 Denoyelle, 
1997 
GJB6/CNX30 DI 3S 1830 Truncation 3 del Casti llo, 
2002 
TMPRSS3 207de!C Truncation Ahmed, 2004 
DFNBB/10 
TMPRSS3 782+3deiGAG Splice site 2 Ahmed, 2004 
DFNBB/10 
PCDH 15/DFNB 1978T>A V5280 Ahmed, 2003 
WFSJIDFNA 2146G>A A7 16T Young, 2001 
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Appendix C: Primer Sequences, Expected PCR Product Size and PCR Conditions 
Used for CDH23 Primers. Taken from Bolz et al. 2001. Primers used the following 
Thermo-cycling Protocol: 95°C for 3 min; three cycles at 95°C for 15 s, AT +4°C for I 0 
s, 72°C for 30 s; three cycles at 95°C for 15 s, AT+2°C for 10 s, 72°C for 30 s; 30 cycles 
at 95°C for 15 s, AT for l 0 s, 72°C for 30 sand 72°C for 10 min. 
Amplified Primer Primer Sequence Size of Annealing 
Ex on Name Fragment Temperature 
(bp) 
1 1f GCTATACCCAGGATAGGACAATGT 465 53 
1r CCTGTGAGAGCTGCAGAAGGCAAC 
2 2f CCTGTGTCACCTTATAGAGTGTGT 242 55 
2r GATGACCTCAACCTGTAAGATCCC 
3 3f GGAAGGCATAAACGTGACCTCTC 327 55 
3r GATGCCACTGTGGAGTCAGAATGG 
4 4f AAGCTCCTAGGGCAATCCTGGAGC 291 50 
4r CACCTTTCCGTGTGATCACCTGG 
5 Sf GGGTCACAGGATTTCTGGACCC 248 55 
5r TTCACCTACACCATGGTGGTCTGG 
6 6f GGCTGAAGGATGTAGAGAATGG 396 55 
6r TGTGTGCCACTGGGTCAATGTCC 
7 7f CCTTCCCTGCTGGAGTGCAAGAGCA 441 55 
7r GCTGTGCCAGAACACTCATCACTGC 
8 8f GCTGTGGGTGCCATGATAGCTA 241 55 
8r CCTCAGAGCCTGAGATGCCTACT 
9 9f TGAGTCTTTAATGCCCAGAGAGG 307 55 
9r CCTCGGACACTGCTGGAGGTTG 
10 !Of GGTAAGCAAGAGCTGTTGCTGTG 391 55 
lOr TTATCCTCAGAACCTACCAGGAG 
I 1 11 f CCAGAAGCTATGGCCCATCAGAGG 373 55 
11 r TGTGACAGTTTGAACAGGTGACACC 
12 12f CCCAACCAAAGCAGCTCTGGG 35 1 55 
12r GGATCTAAGGGAATCTTCTACC 
13 13f CAGAGACTCTAACAGGTGCTCTGG 377 55 
13r CCTGATTGCTGAGGTCCCTTGGAC 
14 14f CCAAAGGAGACGTGCGAGAGGAAC 236 55 
14r GTTCCCAGATCTCATGAGTCTGG 
15 15f GGCAAGGACAGGCTGGGAAATGC 394 55 
15r CAAGCAAGCAAGTACAGGGAGAAG 
16 16f GCCTCCAGTTGAAGCACAAGGG 414 55 
16r TCCTGAGTAGCCCAGAGTGTCAGG 
17 17f CCATGCCAGCCATAACTTCTCTGC 292 55 
17r GTTCACAGGAAGCACTCACCATCC 
18 18f CAGACCTAGCCTGACTCCTTGGTG 276 53 
18r CCTCCCACAATTTGTGTGCAGAGC 
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Appendix C: Primer Sequences, Expected PCR Product Size and PCR Conditions 
Used for CDH23 Primers 
Amplified Primer Primer Sequence Size of Annealing 
Ex on Name Fragment Temperature 
(bp) 
19 19f CACCTCCCTGAGAGCTGGTCACTG 390 55 
19r CTGGTGCTCAAAGCTGGTCTGCTC 
20 20f CCAGATCATGGTAGCTTGCTAAC 355 55 
20r CACAAAGCCTCACACTGGCTCAG 
21 21f GGTGGAGCTGGCAGAATTAATGC 366 55 
21r CTATTGCAAGAGCCAGCTCAGAG 
22 22f ATCTTAGCTGGAATACAGACTCCC 535 55 
22r GGTGATCAGACATAGACCTCCTG 
23 23f CACCACTTGCCTTCTTCCTGTCC 352 55 
23r CTCTGTCCTTCAAGACCCAGCTC 
24 24f CTAGCTGCAGCCAAGTGTGGCTTG 443 55 
24r CCTACAAGTCCAATAGACAGCAG 
25 25f CTACTTGGTCTGGTGCTGGAGAC 327 55 
25r CACCTAGTCTGGCTGTCCATCTG 
26 26f CGCATCAGAGCACCTCAGGCAG 412 55 
26r GTAATGTTTGGTGAGTGCCTGGTGG 
27 27f GGAGTGTGCAAAGTCACAGGAAG 316 55 
27r CCTCTGGTGCCACTGAGCATGTG 
28 28f CGTGAAGGGAAGGAAAGGAACTC 227 55 
28r GACCTTTGGCAGCCTAGAGAAGC 
29 29f CCAACCATGGCAGGCCAGCACAG 304 55 
29r CAACTAATGGCCTTCTCTGTTC 
30 30f CAGGAAAGCAGTGACCACACAAG 328 55 
30r CAGGGATGACCGTTTCGAAGGAG 
31 31f GTGGCAGCTTGAGAAGCCACAGC 538 53 
3lr GTGCACACAGAAGGAGCTCAACC 
32 32f GGACAGAGGAAGTGACATGGAGG 335 53 
32r CGAAGCCTCAGGCTATCAAGACC 
33 33f GCTAGGATGAGACCTCAGGCAGGT 196 55 
33r ACTGGCCACAGCCAACAGCACAG 
34 34f GTTTGCTGATGTTCCAGAACCCAC 382 53 
34r GAAGAACCTGGTGCTTGGTGATG 
35 35f CCAAAAGCCCTTGCTCAACAGAG 327 53 
35r CTCCTGGATGGAGAGTAGTGACC 
36 36f GATTGCACAGCCCTTTTGGACTC 338 55 
36r GTTCCCATCCATGAGATCTGAGG 
37 37f CTACAGGAGCAGGTGCCAGACTG 404 53 
37r CCTGCTGTGTGGAATTCCATTCTC 
38 38f GAGTCACATGGAGTGAGTTCAGC 425 55 
38r CTAGACTGCATCTTTGCTCCATCC 
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Appendix C: Primer Sequences, Expected PCR Product Size and PCR Conditions 
Used for CDH23 Primers. 
Amplified Primer Primer Sequence Size of 
Ex on Name Fragment 
(bp) 
39 39f CCATCACAGCTCCAATGTCAGG 371 
39r GTGAGTTGCTGAGATTAGGACAGG 
40 40f GATAACTCATCCACATGCATAGC 460 
40r CACACAATGGTGAGGCCAAATGC 
41 41f GAGGCTTGCTAGAGGAAGCAGAAG 31 8 
41 r CTCTTGGCACAAGGGTAACAATG 
42 42f GAACCTCCTCCTCGGTTGCCATGC 448 
42r GTGAATCCAAGATTCCATGCTTCC 
43 43f CCAAGCAGAGCAGTTGGCATCTG 554 
43r CAGTGTGTGTCCAGGTATCAGTGG 
44 44f CACTTTGCTGAGCATGGCCTACAAC 367 
44r CTGTCTCTTCCAACCAGACCTGTGG 
45 45f CCAGGCATCTGCGTTCAGTCTGC 353 
45r CCAGAATCAGGCTGGGAGTGCTGG 
46 46f GCAAGAGTCTTGAAGACAGCAGAG 535 
46r GTGTCCAACCTGAGGCTCCAGTCC 
47 47f GGGACTTGAGAAGATCACCAACAA 764 
47r GCTGCTCAAGGGAGGATGAGGAAG 
48 48f CGTGACCCAAGCTTATGAGGAGG 339 
48r CCTGATTGGCTCTGAGTGACCAAT 
49 49f CAAGTGAGCACACCACTGGAAAGC 550 
49r CTGGAATCTGGCATGGAATGCTGG 
50 50f CTCCTCATACTTTGGAGAGCTGC 375 
50r TGCAGGCATCAAGCTGCTCGTGG 
51 51f ATGCCTGCATCAGTGAGTTCTAGG 294 
51r TGGTGGCTGCTCAGTCTCTGACC 
52 52f CTGGTCAGGCAGGTAGCTCCAGG 423 
52r CTTGCTAGAGGCTTTGCTTGTTGC 
53 53f AGGCTTACTCCTGCATGACCAGG 295 
53r CCAAGACATCATGGGTGTCCAAG 
54 54f CTTGGACACCCATGATGTCTTGG 387 
54r CCACAGCTGGAAGAAGGAAATACT 
55 55f GCTGTTGAGGACATTCTGCTACG 465 
55r GGAAGAGCACAGTCAGAGGAAA 
56 56f GCTACAGCTTCCTGAAGACTGCG 511 
56r TGTCTAGCCAAATGTGTATTCTGGC 
Annealing 
Temperature 
55 
53 
55 
55 
55 
53 
55 
53 
55 
50 
53 
53 
53 
53 
53 
53 
55 
53 
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Appendix C: Primer Sequences, Expected PCR Product Size and PCR Conditions 
Used for CDH23 Primers 
Amplified Primer Primer Sequence Size of 
Ex on Name Fragment 
(bp) 
57 57f CCTCAGCACCTACAAAGTCACTGC 291 
57r GGCATATGTGGGTCATCTCTAGC 
58 58f GCTAGAGATGACCCACATATGCC 449 
58r CCAGCACCTGGATCAACTCTGAGC 
59 59f AGTACACTGCAGGTGCAGGGACTG 308 
59r CATGCAGTGACTGAGAGGTCATGG 
60 60f CCACTTGCCTGTCACCTTTGCTC 654 
60r CCAATCACTTCATCCACACTTGG 
61 61f CCAAGTGTGGATGAAGTGATTGG 500 
61r GAATACTCCCATGTTACAGATGG 
62+63 62+63f GGTTGTTGAACTTTGGAGGCTTGAG 54 1 
62+63r TACCAGCTGAGCCAGCCACAATGG 
64 64f CGATCATCGTCCTGGCTATCCTCC 327 
64r CCTGAGCCAGGCTTGTGGCTCC 
65 65f GGACACAGGTGAGAAGGCAGTGG 421 
65r CCTGTCAGCCACGTGGTTTCTGAGG 
66 66f CCAAGTCAGTGAAAGGCACTATATG 31 8 
66r CCAGAGGTTGCAAAGACCCAGC 
67 67f CCAAGAAGCTGGGTTCTTTAAGG 288 
67r CCACCCTGTGTTCTCTGGAGTGG 
68 68f CCTAGGATCACCAGGATCAGATGTC 330 
68r TCCTGGCTGCAGAGCTCCAGAGA 
69 69f CCAAGGTTCAGCCACATAGCCAGT 589 
69r AAGTGGGATCTGAGCAGCTGATGC 
Annealing 
Temperature 
53 
55 
53 
57 
55 
53 
55 
55 
55 
55 
55 
57 
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